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Macrophages play a key role in the immune response destroying pathogens directly or 
releasing mediators which can activate other cells. However, macrophages from aged 
mice present defects in their functional activities due to the aging process that alter the 
immune response. Cellular senescence is characterized by a permanent cell cycle 
arrest and is produced after continuous duplication/reproduction of a cell. The 
accumulation of senescent cells seems to be involved in and is responsible for the 
induction of aging. In this regard, due to the difficulty of working with old mice as a 
source of aged macrophages, in the present study we have considered whether the 
functions of long-lasting cultures of macrophages from young mice resembles to the 
functions found in senescent cells responsible for the aging patterns previously 
described.   For this purpose, we have compared a normal macrophage culture (0 days 
macrophages) and long-period macrophage culture (14 days macrophages) of bone-
marrow derived macrophages from 6-weeks old Balb/c mice. 
Macrophages from 14 days cultures were positive for senescence markers such as 
telomere shortening and high β-galactosidase activity. Macrophage senescence was 
correlated with a reduced proliferation in response to specific growth factors (M-CSF 
and GM-CSF) due to an increase of cells in G1 phase of the cell cycle. In addition, 
long-lasting macrophage cultures showed a great number of altered macrophage 
functions such as antigen presentation and microbicidal reduced capacities and defects 
in alternative activation, indicating that both pro-inflammatory and anti-inflammatory 
phenotypes were impaired in these cells which correlate with that observed in 
macrophages from aged mice, as it was previously demonstrated in our laboratory. 
All these data suggest that cellular senescence induced in long-lasting macrophage 
cultures is a good tool to evaluate the altered macrophage functions and characteristics 
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1. Macrophages in the innate immune system 
 
The innate immune system is an evolutionarily conserved system acting as a first-line 
of defense against invading microbial pathogens and other potential threats to the host 
(Rescigno, 2009; Clarke et al., 2010; Hand and Belkaid, 2010). The mucosal surfaces 
of mammals are in constant interaction with a multitude of commensal and pathogenic 
microorganisms that include bacteria, viruses, parasites, fungi and protozoa, 
constituting a diverse microbial ecosystem (Xu and Gordon, 2003). Therefore, the 
innate immune system has evolved to rapidly detect and respond to harmful stress 
situations and infectious agents (Kanneganti et al., 2007). This is coordinated by 
myeloid sentinels, mainly macrophages and dendritic cells, which express a limited 
number of evolutionarily conserved germline-encoded pattern-recognition receptors 
(PRRs) (Bauernfeind and Hornung, 2013). 
PRRs recognize conserved microbe-specific molecules such as specific nucleic acid 
structures of microorganisms, microbial cell wall components (lipopolysaccharide, LPS) 
or lipoproteins and structural proteins for microbial mobility (flagellin) (Franchi et al., 
2012). Moreover, PRRs also detects a set of host-derived molecules released from the 
plasma membrane, nucleus, mitochondria, endoplasmic reticulum and cytosol as ATP 
or urate crystals (Kobayashi et al., 2010). These molecules are secreted upon “danger” 
signals, such as cellular stress, damage or non-physiological death and modulate the 
immune system playing important roles in inflammation and tissue repair processes 
during infection (Krysko et al., 2011).  
PRRs can be classified according to their ligand specificity, function, localization and/or 
evolutionary relationships. The main families of PRRs include the Toll-like receptors 
(TLRs), the nucleotide oligomerization domain(NOD)-like receptors (NLRs) and the C-
type lectin receptors (CLRs) (Kawai and Akira, 2006). TLRs and CLRs recognize 
mainly extracellular and endosomal microbial signals and facilitate signal transduction 
across cell membranes, leading to pro-inflammatory gene expression through the 
transcription factor NF-kB (Akira and Takeda, 2004; Pizarro-Cerda and Cossart, 2006). 
If the bacteria invade the cell, cytosolic PRRs mainly those belonging to the NLRs 
family aid in amplifying pro-inflammatory responses (Strober et al., 2006; Mariathasan 
and Monack, 2007). Recently, other PRR families that appear to guard the intracellular 
environment have emerged. These include the RIG-I-like receptor (RLR) and the 




Then, microorganisms modulate the innate immune system through the activation of 
multiple PRRs together or sequentially (Franchi et al., 2012). In the inflamed tissue, the 
recognition of microbial agents by macrophage PRRs leads to a multitude of 
transcriptional and posttranslational modifications that result in pro-inflammatory 
cytokines, chemokines and growth factors being secreted into circulation in a high 
coordinated manner. These factors induce the migration of polymorphonuclear 
leukocytes and professional phagocytes to the site of infection or injury, to rapidly 
eliminate the pathogen and repair the damage (Lamkanfi and Dixit, 2012).  
In this sense, alterations in the innate immune system regulation due to disorders in 
immune responses can lead to chronic inflammation, tumorigenesis, tissue destruction 
and autoimmune diseases (Coussens and Werb, 2010; Elinav et al., 2013).  
 
1.1 Macrophage origin and differentiation 
 
In this context, the mononuclear phagocyte system which embraces a family of cells 
that includes committed precursors in the bone marrow, circulating blood monocytes 
and tissue macrophages and dendritic cells has acquired great importance in the study 
of different pathologies in the last years (Hume, 2008). Cells of the mononuclear 
phagocyte lineage progress through a series of defined morphologically distinct stages; 
a common myeloid progenitor shared with granulocytes giving rise to monoblasts, 
promonocytes, and thence monocytes, which migrate to the tissues (Takahashi, 2000).  
Metchnikoff originally identified and characterized macrophages more than 100 years 
ago, and his phagocytosis report won him the Nobel Prize for Medicine in 1908. The 
growth and differentiation of macrophages is produced into tissues and depend on 
lineage-determining cytokines, such as macrophage colony-stimulating factor (M-CSF) 
and granulocyte–macrophage colony-stimulating factor (GM-CSF), and is defined by 
interactions with stroma in haematopoietic organs (Celada and Nathan, 1994). 
Interleukin-3 (IL-3), KIT, tumour-necrosis factor (TNF)-family proteins and TNF-
receptor-related molecules contribute to macrophage determination, as do key 
transcription factors such as PU.1 (Gordon, 2003; Hume, 2008).  
A common progenitor gives rise to tissue macrophages, myeloid dendritic cells (DCs) 
and osteoclasts, which are distinct, irreversibly differentiated sublineages (Lech et al., 




they are constitutively distributed, enter into all tissue compartments of the body. These 
migration processes (Figure 1) are produced through the interaction between adhesion 
molecules at the surface of monocytes and vascular endothelial cells (Valledor et al., 
1998). Adhesion molecules control cell migration from the blood and through 
endothelia, the interstitium and epithelia. These include integrins (β1, β2 and others), 
immunoglobulin-superfamily molecules (such as CD31), selectins and epidermal 
growth factor seven-transmembrane spanning (EGF-TM7)-type receptors related to the 
F4/80 (EMR1) antigen (Lech et al., 2012). Cytokines such as transforming growth 
factor-β, chemokines and growth factors, often bound to local proteoglycans, influence 
the expression of a range of macrophage genes (Hume, 2008). During monocyte 
migration into tissues, monocyte maturation ends and then they undergo differentiation 
to become multifunctional tissue macrophages. In this sense, monocytes are 
considered to be immature macrophages (Gordon, 2003). Resident macrophage 
populations (Figure 1) in different organs, such as Kupffer cells (liver), alveolar 
macrophages (lung) and microglia (central nervous system, CNS), adapt to their local 
microenvironment since they are required to perform particular functions. The signals 
that are responsible for tissue-specific phenotypes of macrophages include surface and 
secretory products of neighbouring cells, and extracellular matrix (Gordon, 2003). 
Moreover, it is possible that monocyte-derived tissue macrophages can re-enter the 
bloodstream and differentiate into dendritic cells, depending on local stimuli such as 
phagocytosis (Gordon, 2003). 
 
 
Figure 1. Macrophage differentiation process. IL, interleukin; M-CSF, macrophage colony- 
stimulating factor from macrophages, GM-CSF, granulocyte-macrophage colony-stimulating 




Tissue-resident macrophages cease to proliferate, but they undergo local activation in 
response to various inflammatory and immune stimuli (Hume, 2008). The enhanced 
recruitment of monocytes and precursors from bone-marrow pools results in the 
accumulation of tissue macrophages that have enhanced turnover and an altered 
phenotype. These macrophages are classified as being 'elicited', as in the antigen-non-
specific response to a foreign body or sterile inflammatory agent, or as being 
'classically activated' or 'alternatively activated' by an antigen-specific immune 
response (Gordon, 2003) (see point 1.2). Nevertheless, it is difficult to distinguish 
originally resident macrophages from more recently recruited, elicited or activated 
macrophages, because macrophages adapt to a particular microenvironment.  
 
Thus, macrophages in a steady state or during an inflammatory process are a crucial 
part of the host defense fighting pathogens during an infection and, once resolved, in 
wound healing processes. But they also can be harmful, causing or exacerbating 
inflammatory diseases such as osteomyelitis, atherosclerosis and multiple sclerosis. All 
these indicate that these cells have a high phenotypical plasticity according to the 
environment conditions (Biswas and Mantovani, 2010).  
 
1.2 Macrophage sutypes 
  
Macrophages are a heterogeneous population of innate myeloid cells with diverse 
functionality due to different transcriptional profiles. Their main function is to recognize 
pathogens and orchestrate a signaling response in order to modulate the adaptive 
immune response through antigen processing and presentation. These cells are also 
key regulators in processes centered on generation and resolution of inflammation, as 
well as tissue repair (Mosser and Edwards, 2008). In addition, macrophages are 
required to maintain homeostasis which involves phagocytosis of debris and 
pathogens, dead cell clearance and matrix turnover processes (Steinman and Idoyaga, 
2010). 
The multifunctionality of macrophages is associated to the type of macrophage 
receptor involved or activated and the presence of determined cytokines in the 
microenviroment (Taylor et al., 2005). Analogous to the T helper type 1 (Th1) and T 
helper type 2 (Th2) polarization, macrophages have been defined in two different 




and the alternatively activated (M2) macrophage phenotype (Figure 2) (Mantovani et 
al., 2002; Gordon and Taylor, 2005). 
Classical activation provides to macrophages their characterization as effector cells in 
Th1 cellular immune responses. The recognition of LPS and the signaling pathways 
induced by IFN-γ, a Th1 type cytokine, polarize macrophages towards the pro-
inflammatory phenotype (M1 phenotype) which induces the production of large 
amounts of pro-inflammatory cytokines such as TNF-α, IL-12 and IL-23 (Figure 2). The 
secretion of this kind of cytokines supports the induction of adaptive immune responses 
based on Th1 and Th17 cell inflammatory processes. Furthermore, the antimicrobial 
functions of M1 macrophages are associated to up-regulation of enzymes, such as 
inducible nitric oxide synthase (NOS2) that generates nitric oxide (NO) (MacMicking et 
al., 1997).  
In contrast, the alternative activation of macrophages seems to be involved in 
immunosuppression and tissue repair. The signaling pathway induced by Th2 type 
cytokines, such as IL-4, produces an anti-inflammatory macrophage phenotype (M2 
phenotype) which drives to the secretion of high levels of IL-10 and IL-1RA and low 
expression of pro-inflammatory cytokines (Hao et al., 2012). M2 macrophages act as 
immunoregulators exerting diverse functions that favor elimination of parasites, 
reduction of inflammation, promotion of tissue remodeling and proliferation (Hao et al., 
2012). 
M2 macrophages can be further divided into different subsets (Figure 2): M2a, M2b, 
and M2c based on gene expression profiles (Mantovani et al., 2004). The M2a subtype 
is produced by IL-4 or IL-13. The M2b is elicited by IL-1R ligands or exposure to 
immune complexes plus LPS. The M2c subtype is generated by IL-10, TGF-β and 
glucocorticoid hormones (Hao et al., 2012).  
In addition, it has also been described a fourth type of M2 macrophage, the M2d 
macrophage phenotype. This subset of macrophages is characterized by an IL-10high 
and IL-12low, as normal M2 profiles, but with some features of tumor-associated 
macrophages (TAMs) (Duluc et al., 2007). 
As it has been mentioned before, M-CSF and GM-CSF cytokines are implicated in the 
differentiation of monocytes to macrophages. However, GM-CSF can also polarize 
monocytes to M1 macrophage subtype with a pro-inflammatory cytokine profile (e.g. IL-
23), and treatment with M-CSF produces an anti-inflammatory cytokine profile (e.g. IL-





Figure 2. Macrophage subsets. The proposed M1-M2 macrophage model includes M1 
phenotype induced by IFN-γ, LPS or TNF-α and M2 phenotype subdivided to define 
similarities and differences between IL-4 (M2a), immune complex + TLRs ligands (M2b), and 
IL-10 and glucocorticoids (M2c). Adapted from Martinez and Gordon, 2014. 
 
Interestingly, although both phenotypes exhibit many distinct characteristics, they are 
involved in arginine metabolism through distinct biochemical pathways to produce their 
definitive features. Th1-type cytokines or conserved microbial structures induce 
macrophage NOS2, which oxidized arginine into OH-arginine and then into NO. In 
contrast, Th2-type cytokines induces the expression and activation of arginase-1 which 
metabolizes arginine into urea and ornithine, which is then subsequently converted into 
proline and polyamines (putrescine, spermidine, and spermine). Proline mediates the 
production of collagen, while polyamines induce cell proliferation. Therefore, 
macrophage activation requires high concentrations of arginine either for the 
microbicidal activity required to eliminate pathogens or for the restoration of the tissue 
and the extracellular matrix (Classen, 2009). In this sense, the involvement of different 
pathways sharing a common substrate suggests that macrophages present plasticity 
between these phenotypes. 
In the last years, several works have explored the expression of gene markers that 
could characterize M1 and M2 macrophage populations. In this sense, several markers 
have been related with M1 phenotype such as TNF-α, IL-1β and IL-6 (Loke et al., 2002; 
Martinez et al., 2008).  In the case of alternative activation, although there are several 
controversies, it seems clear that at least in mice, besides arginase-1 (arg1), other 




(MR) encoded by mrc1 gene, galactose receptor (GR) encoded by mgl1 gene, 
“resistin-like” (Relm; also referred as “found in inflammatory zone” (fizz1)), transforming 
growth factor β (tgfβ), chitinase-like molecules (also called ym1/2) and the nuclear 
associated peroxisome proliferator-activated receptor γ (pparγ). The vast majority of 
these M1 and M2 markers are highly regulated at transcriptional level during 
macrophage polarization (Mosser and Edwards, 2008; Gordon and Martinez, 2010).  
Many works have been reported regarding to the study of M1/M2 regulation.  They 
found different and essential signaling pathways and transcription factors upstream of 
the expression of M1 and M2 related genes. Although it has been established that 
STAT1 and STAT6 plays a crucial role in the IFN-γ and IL-4 signaling, respectively 
(Classen, 2009), several publications have showed the role of certain transcription 
factors to generate any of both macrophages activation phenotypes. This is the case of 
NF-κB; NF-κB subunit p50 has been associated with the alternative activation of 
macrophages (Porta et al., 2009), whereas NF-κB subunit p65 is clearly involved in the 
signaling pathway required for the classical phenotype (Ray et al., 2010). 
This classification of macrophage subsets is based on the establishment of differences 
and similarities in macrophage responses to diverse stimuli. In this sense, the main 
limitations of the current view are, first, it ignores the source and context of the stimuli, 
second, the M1 and M2 stimuli do not exist alone in tissues and third, macrophages 
may not form clear-cut activation subsets nor expand clonally. In addition, updated 
knowledge of cytokine signaling, the role of cytokines in the development of the 
hematopoietic system and transcriptomic and proteomic analysis reveal a far more 
complex picture (Martinez and Gordon, 2014).  
 
1.3 Inflammatory response 
 
Inflammation is a tightly regulated process initiated after tissue injury or infection. The 
inflammatory process has as main function restore homeostasis eliminating the 
aggression and removing the injured tissue (Allen et al., 2010; Dupaul-Chicocine et al., 
2010; Zaki et al., 2010). In this sense, the coordinated feat of professional phagocytes 
(neutrophils, monocytes and macrophages) is critical. 
The phagocytic activity and microbicidal capacity of macrophages are crucial to 
achieve the eradication of the pathogenic agent. In normal physiological conditions, 




clearance of apoptotic cells and the secretion of growth factors (Geissmann et al., 
2010). However, in a situation of microbial invasion macrophages activities go far 
beyond eating and killing, they also regulate innate and adaptive immunity producing 
several cytokines and chemokines and present antigens to activate and differentiate T 
cells linking the innate with adaptive immunity (Gordon, 2003). 
Once the aggression occurs, during the early stages of the inflammatory response 
(Figure 3), macrophages are activated classically inducing pro-inflammatory M1 
phenotype, as it has been mentioned before (see point 1.2). In this phase, M1 
macrophages produce diverse mediators, such as cytokines, NO and ROS that destroy 
pathogens combined with an increased expression of major histocompatibility complex 
(MHC) class II and CD86 enhancing their antigen-presenting capacity to T lymphocytes 
(Gordon, 2003). The persistence of inflammation often results in tissue damage and 
the immune system permanently is challenged for developing anti-inflammatory 
mechanisms (Martinez and Gordon, 2014). 
When the pro-inflammatory stimulus is removed from the inflamed tissue, 
macrophages are alternatively activated, M2 phenotype, by Th2-type cytokines (Figure 
3), such as IL-4 or IL-13, and initiate anti-inflammatory processes to reconstruct the 
damaged tissue with the removal of apoptotic cells, production of collagen, etc., 
(Classen et al., 2009). Moreover, M2 macrophages exhibit enhanced phagocytic 
activity and increased expression of MHC class II molecules for antigen presentation 
(Martinez and Gordon, 2014). Therefore, anti-inflammatory macrophages protect 
organs and surrounding tissues against detrimental immune responses promoting 
tissue remodeling. 
Several in vitro studies have shown macrophages adaptation to a changing 
microenvironment (Stout and Suttles, 2004). It has been shown that macrophages in 
vitro are capable of complete repolarization from M2 to M1, and change again in 
response to fluctuations in the cytokine environment (Davis et al., 2013). However, 
there are contradictory opinions about this fact because it is not known what extent 
these distinct activation states exist in vivo and whether macrophage phenotype is 
determined forever or whether it remains constantly malleable (Gordon and Taylor, 
2005). Ma and co-workers demonstrated that M2 macrophages presented within the 
inflammatory tissue were not recruited from the blood, they were derived from M1 
macrophages (Ma et al., 2011). Then, after M1 activation of macrophages they can 
become to M2 phenotype in the inflammatory locus. This conversion was called 




protein, metabolite and microbicidal activity (Kuroda et al., 2009; Davis et al., 2013). In 
addition, it has been hypothesized that phagocytosis could be involved in the switch 
from M1 to M2 or from inflammatory to anti-inflammatory macrophages (Arnold et al. 
2007).  In this sense, phagocytosis drives to the final steps of the pro-inflammatory 
phase eliminating the remaining microorganisms and also participates in the tissue 
repair removing apoptotic and senescent cells (Valledor et al., 2010). However, due to 
the variety and complexity of phagocytosis processes, further studies are required to 















Figure 3. Schematic overview of the inflammatory response process. After the initial 
homeostasis phase, neutrophils and M1 macrophages dominate the inflammation phase 
of the inflammatory response destroying pathogens. Once the microbial agent is 
eliminated, macrophages are polarized to M2 phenotype in order to repair injured 
tissues.  
 
1.4 Other macrophage functions 
 
Due to the key role played by macrophages in the immune system we generally forget 




macrophages participate in development, bone resorption and iron and cholesterol 
metabolisms (Gordon et al., 2014).  
 
The importance of macrophages in development is emphasized by the numerous 
systems affected by macrophage depletion in the M-CSF-deficient mouse, including 
somatic growth, development of the pancreas and nervous system, and male and 
female fertility (Pollard, 2009; Gow et al., 2010).  As an example, Langerhans cells 
(epidermal macrophages) contribute to the control of proliferation and differentiation of 
keratinocytes (Lau et al., 2008).  
Another critical macrophage-related cell is the osteoclast. Osteoclasts are 
multinucleated giant cells formed in bones by fusion of monocyte-like cells in the 
presence of M-CSF (Helming and Gordon, 2007). Collaborating with osteoblasts, these 
cells participate in bone production and remodeling. However, the main function of 
osteoclasts is to resorb living bone, by integrin-dependent adhesion to the bone 
surface. Moreover, they are able to regulate the differentiation of osteoblast precursors 
and the movement of hematopoietic stem cells from the bone marrow to the 
bloodstream (Takayanagi, 2007). 
In addition, stromal macrophages have been implicated in the metabolism of iron 
(Hanspal and Hanspal, 1994; Sadahira, et al.,, 1995; Spring et al., 2013). These cells 
express EbR, which promotes adhesion of erythroblasts and myeloblasts (Morris et al., 
1991) and CD163, involved in iron recycling from heme, after uptake of erythrocytes 
(Kristiansen et al., 2001). 
 
Finally, macrophages are also involved in the uptake of modified lipoproteins and 
cholesterol by scavenger receptors such as CD36 and CD68 (Moore and Freeman, 
2006). The internalization of these molecules results in foam cell formation and the 
polarization to M1 macrophages inducing an inflammatory response. Furthermore, 
these cells alter the expression of genes involved in lipid metabolism, secretion of pro-









2. Cellular senescence 
 
Cellular senescence is an irreversible program of cell cycle arrest triggered in normal 
somatic cells in response to a variety of intrinsic and extrinsic factors including 
telomere attrition, DNA damage, physiological stress and oncogene activation (Kuilman 
et al., 2008). 
Cellular senescence was officially described more than five decades ago when Hayflick 
and co-workers demonstrated that diploid cells had a restricted capacity to multiply in 
culture (Hayflick and Moorhead, 1961). This fact was interpreted as an organismal 
protective mechanism from cancer, since cancer cells proliferate indefinitely in vitro, 
and as the origin of aging at organ and organismal levels, typified by the loss of 
regenerative capacity and functionality of tissues in vivo. In this sense, senescent cells 
have been observed in mammals in association with aging (Nussey et al., 2013).  
These findings suggest that cellular senescence can be by one hand beneficial (tumor 
suppressive) and by the other hand deleterious (limit tissue restitution). Although some 
researchers assume that natural selection has favored genes providing advantages to 
the organism during the reproductive years, at the expenses of deterioration in the 
distant future (Kuilman et al., 2008), recently Blagosklonny and collaborators 
understand senescence process as the result of two opposing signals: cell growth and 
the blockage of cell cycle (Blagosklonny, 2013). 
Thus, cellular senescence is a permanent condition in which normal cells are unable to 
proliferate further (Campisi and D’Adda di Fagagna, 2007). In contrast to cellular 
quiescence, senescence cannot be reversed by altering the cellular environment, by 
removing cell contact inhibition or providing abundant nutriments in vitro (Serrano, 
2010). Furthermore, senescence is distinct from terminal differentiation, as it is not the 
end of a programmed differentiation process (Shay and Wright, 2005).  
Senescent cells, even they stop proliferation and synthesize DNA, are viable almost 
indefinitely in vitro. They typically suffer dramatic morphological and functional changes 
and present an altered gene and protein expression profile (Serrano and Blasco, 2001; 
Narita et al., 2003). To characterize and detect senescent cells different biochemical 
assays have been developed such as senescence associated-β-galactosidase staining 
(SA-β-Gal) (Dimri et al. 1995; Shelton et al. 1999; Pascal et al. 2005), telomere 
dysfunction (Sebastián et al., 2009) and activation of DNA damage response (Takai et 




connected with known senescent signaling pathways and, therefore, senescence 
mechanism requires further investigations to be entirely defined. 
 
2.1 Morphological and molecular changes in senescence 
 
Upon entering senescence, cells suffer dramatic modifications. Senescent cells acquire 
large volume, flattened cytoplasm morphology accompanied by changes in nuclear 
structure, gene expression, protein processing and metabolism (Campisi et al., 1996; 
Campisi, 1997; Chen, 2000). These alterations are also observed during the process of 
aging in vivo (Dimri et al., 1995; Campisi, 2000; Narita et al., 2003). 
 
Most of the mechanistic studies of senescence have been focused on the irreversible 
growth arrest (Parajuli et al., 2014; Renna et al., 2014; Zhang et al., 2015). However, 
the cause of cell enlargement has not been well studied. Some works link senescent 
morphogenesis with cell cycle arrest since it is believed that both phenomena are 
connected (Kuilman et al., 2010). In this sense, senescent morphogenesis could be a 
programmed event involving cell cycle checkpoint proteins which control the 
morphological changes, such as p53 and Rb whose hyperphosphorylation abrogate the 
cell cycle and is also linked with senescence morphology (Chen et al., 1998).  
 
A large number of morphological studies focus on cytoskeletal proteins, mainly in actin 
polymerization (Hou et al., 2013; Biran et al., 2015). In this sense, it has been 
demonstrated that senescent cells although present similar protein levels of actin they 
have an increased rate of actin polymerization or decreased rate of actin filament 
depolymerization (Chen et al., 2000), necessary to maintain the enlarged cells. 
However, the involvement of cell cycle checkpoint proteins is not clear. The inactivation 
of Rb is necessary but not sufficient for senescence morphogenesis, supporting that 
alteration in senescent morphology is not simply a consequence of inhibition of cell 
proliferation (Chen et al., 2000). 
 
Changes in cell morphology and adhesion are important parameters of cancer 
metastasis and invasion (Button et al., 1995; Gumbiner, 1996). Tumor cells are often 
smaller and have less actin stress fibers compared to their normal counterparts (Otto, 
1990; Button et al., 1995; Zigmond, 1996). Therefore, it is believed that senescent or 
senescent-like cells could contribute to tumor suppression at least by cell enlargement 




2.2 Factors inducing cellular senescence 
 
The extensive sets of stimuli that can induce senescence indicate the complexity of the 
senescence process. The growth arrest is due in part to the gradual loss of DNA at the 
ends of chromosomes (telomeres shortening), produced in each cell division 
(Nakamura et al., 2008). Short telomeres originate a persistent DNA damage response 
(DDR), which initiates and maintains the senescence growth arrest (d’Adda di 
Fagagna, 2003; Takai et al., 2003; Herbig et al., 2004; Rodier et al., 2009; Rodier et al., 
2011). In fact, DNA double strand breaks inducers, such as ROS, are particularly 
effective senescence inducers (DiLeonardo et al., 1994). Moreover, histone 
deacetylase inhibitors (HDACi), which relax chromatin, activate the DDR response 
triggering ATM and p53 proteins activation (Bakkenist and Kastan, 2003), and 
promoting senescence (Ogryzko et al., 1996; Munro et al., 2004), as it has been 
demonstrated by sodium butyrate, a well-known HDACi (Vargas et al., 2014). Finally, 
many normal cells become senescent after robust mitogenic signals produced by 
oncogenes (ras, raf and c-myc) or pro-proliferative genes (E2F) (Serrano et al., 1997; 
Lin et al., 1998; Zhu et al., 1998; Dimri et al., 2000; Davis, 2012) which enhance DDR 
by failed replication origins and replication fork collapse (Bartkova et al., 2006; Di Micco 
et al., 2006; Mallette et al., 2007).  
 
However, senescence can also be caused without DDR signaling through “culture 
stress” (tissue culture plastic, serum, etc) not detected in vivo (Fusenig and Boukamp, 
1998; Ramirez et al., 2001; Yaswen and Stampfer, 2002; Parrinello et al., 2003). In 
these circumstances cells induce pro-proliferative/pro-survival kinases (Alimonti et al., 
2010) and increase the expression of the cyclin-dependent kinase inhibitors (CDKi), 
such as p21WAF1 and p16INK4a that normally enforce the senescence growth arrest (Mc-
Connell et al., 1998; Rodier et al., 2009).  
 
2.2.1 Cellular senescence induced by telomere shortening 
 
Historically, telomere shortening has been implicated as one of the major mechanisms 
of replicative senescence (Hayflick’s limit) (d’Adda di Fagagna, 2008). Human 
chromosome telomere ends are special structures composed of stretches of repetitive 
tandem hexameric units-TTAGGG and associated telomeric proteins that cap the ends 




process (Reaper et al., 2004) (Figure 4).  The length of human telomeres ranges from 
a few to 10–15 kbs.   
The term “end-replication problem” describes the inability of standard DNA 
polymerases to fully replicate the ends of the chromosomes which are consequently 
shortened at each mitotic cycle (Campisi and D’Adda di Fagagna, 2007). This causes 
the estimated loss of around 50 to 200 base pairs during each cycle of replication at 
the 5′ end of the lagging strand. Therefore, when the length of one or more telomeres 
gets below a certain threshold (1-4 kbs), the exposed telomeric DNA ends are 
recognized as double-strand breaks (DSBs) by the DNA damage response (DDR) 
mechanism (explained in section 2.2.2) driving to senescence.   
Although telomere shortening might not be primarily involved in the acute induction of 
senescence (Shay and Wright, 2005), together with the accumulation of oxidative 
stress (see section 2.2.2) might increase the possibility of a cell to enter in cellular 
senescence. It has been reported that replicative telomere attrition with high levels of 
DNA damage can result in an increase of senescent cells in different tissues and 
organs ultimately resulting in decreased function and pathology and causing 
organismal aging (Von Zglinicki et al., 2005).  
 
 
Figure 4. Telomere attrition. Size of telomeres is shortened in each cell division until a 
critically telomere length that induces senescence.   
 
The discovery of the reverse transcriptase telomerase revolutionized the telomere 




the telomeres. In this sense, telomerase deficient mouse has inactive telomerase and 
consequently reduced telomere length in each following generation causing premature 
aging (Di Leonardo et al., 1994). 
Some works try to link telomere length with lifespan, although this hypothesis is still not 
clear. It has been estimated that females have longer telomeres than men and in 
African Americans telomeres generally are longer than in White Americans (Rodier et 
al., 2011). In addition, mice strains with longer telomeres do not seem to have an 
increased lifespan compared to mice strains with shorter telomeres. How these 
variations in telomere size alter lifespan are still unknown, although the most putative 
premise is that the shortest telomeres are contributing most to the expected lifespan 
(Robles and Adami, 1998).  
 
2.2.2 Cellular senescence induced by DNA damage 
 
The human genome is constantly exposed to genotoxic stress, such as radiation (X or 
γ-rays, UV) and DNA-interacting drugs (bleomycin, doxorubicin, mitomycin, etoposide) 
and oxidative stress (Robles and Adami, 1998; Touissant et al., 2002; Parrinello et al., 
2003; Bavik et al., 2006). Oxidative stress results in formation/accumulation of reactive 
oxygen species (ROS) (Chen et al., 1998; Reina-San-Martin et al., 2003; Blander et al., 
2003). The generation of ROS and free radicals is considered as one of the 
mechanisms of aging, affecting DNA and other cellular constituents and activating the 
transcription of inflammatory genes (Langen et al., 2003; Ramsey and Sharpless, 
2006).  According to some data, oxygen radicals can also directly participate in the 
induction of senescence (Serrano et al., 2007). 
These diverse factors can cause DNA double-strand breaks (DSBs), the most 
dangerous type of DNA damage, with a similar structure to short or dysfunctional 
telomeres (Von Zglinicki et al., 2005). DSBs are associated with physiological 
processes as a consequence of metabolism (Takahashi and Ohnishi, 2006). 
To guarantee the integrity of the genome, cells activate a refined protective system that 
stops cell cycle to allow the repair of the damage. It was demonstrated that the Ser139 
phosphorylation of histone H2A, called H2AX, is immediately induced by DSBs 
(Rogakou et al., 1998). The phosphorylated form of H2AX is referred to as γ-H2AX 
(Rogakou et al., 1998; Helt et al., 2005) which stops cell cycle progression and 




Kastan, 2003). Thus, H2AX phosphorylation is a useful marker for DSBs detection 
(Rogakou et al., 1999). 
The first phase of the repair process is the detection of DNA damage through 
Mre11/Rad50/NBS1 (MRN) complex whose assembly is induced by H2AX 
phosphorylation and functions as a DNA damage sensor (Matsuda et al., 2013). This 
important complex is localized in nuclear foci around the breaks stabilizing the structure 
and prepares it for potential repair (Zhao et al., 2008). In this sense, H2AX-knockout 
cells present impaired recruitment in DNA repair foci of NBS1 protein of the MRN 
complex and 53BP1 and BRCA1 (mediator proteins of DNA damage response) 
(Celeste et al., 2003) which consequently produces defects in DNA damage repair and 
chromosome abnormalities (Petersen et al., 2001; Bassing et al., 2002; Reina-San-
Martin et al., 2003, Xie et al., 2004; Kao et al., 2006).  
One of the most critical kinase-activating cell cycle checkpoints following DNA damage 
is ATM (ataxia-telangiectasia mutated) (Ostan et al., 2008). ATM kinase is considered 
as a major physiological mediator of H2AX phosphorylation in response to DSB 
formation (Kastan and Lim, 2000; Bakkenist and Kastan, 2003). In addition, the MRN 
complex is also involved in the recruitment and activation of ATM and ATR (ATM and 
Rad3related) protein kinases, which in turn activate checkpoint-1/2 (CHK1/2) kinases 
leading to phosphorylation and thereby stabilization of a variety of target genes 
including p53 (Ou et al., 2005).  
When DNA injuries are repairable, cells temporary stop proliferation and repair the 
damage through the mechanism described above (Rodier et al., 2011). In contrast, 
severe or irreparable DNA damage, such as complex breaks or uncapped telomeres, 
causes many cells to senesce or die with persistent DNA damage foci, constitutive 
DDR signaling and chronic p53 activation. These persistent changes precede 
establishment of senescence-associated phenotypes, including growth arrest 
(Tchkonia et al., 2013) and senescence-associated secretoy phenotype (SASP) (Wu et 








Figure 5. DNA damage response. The activation of H2AX triggers a signaling pathway 
initiated by the formation of the MRN complex. Then activated ATM and ATR kinases 
induce the activation of DNA damage response checkpoint driving to the phosphorylation 
of p53 and abrogating the cell cycle progression. Depending on the damage level and 
the circumstances of the cell, cells repair the damage, or become apoptotic or 





2.2.3 Cellular senescence induced by oncogenes and hyper-proliferative 
signals  
 
Oncogenes are mutant forms of normal genes that have the ability to transform cells 
stimulating uncontrolled cell division (Gorgoulis and Halazonetis, 2010). However, 
induction of senescence or apoptosis is the frequent outcome of oncogene activation in 
normal cells. In this sense, senescence induction must be directed to neutralize 
excessive activation of the cell cycle that drives oncogenic transformation (Campisi and 




protective mechanism to elude tumor formation because avoids the proliferation of cells 
that overexpressed aggressive oncogenes.   
The pathways mediating OIS are not totally clarified but, the irreversible cell cycle 
blockage involves activation of both Rb and p53 pathways (Braig and Schmitt, 2006) 
accompanied by the upregulation of the CDK inhibitors p15INK4B, p16INK4A and p21 
(Reddy and Li, 2011).  
OIS can be triggered by E2F1, c-myc and Ras  (Grandori et al., 2003; Lazzerini et al., 
2005; Courtois-Cox et al., 2006). The increase of Ras was demonstrated to trigger cell 
division followed by growth arrest produced by the accumulation of p53 and p16INK4A 
proteins and the phosphorylation of pRb (Serrano et al., 1997), suggesting 
resemblances to tumor suppressor mechanisms.  The proof of OIS has been 
demonstrated in vivo in human and mouse tumor models (Braig et al. 2005; Chen et al. 
2005; Collado et al. 2005; Michaloglou et al. 2005; Courtois-Cox et al. 2006; Dankort et 
al. 2007). Furthermore, mutations in Ras and Raf have been observed to induce 
cellular senescence in vivo. Senescence occurs in benign but not in advanced tumors, 
supporting the first in vitro observation that activation of these pathways lead to an 
initial burst of proliferation before causing cellular senescence (Courtois-Cox et al., 
2008).   
Additionally, similar to replicative senescence, oncogene-induced senescence has a 
causal link to reactive oxygen species (ROS) accumulation and can be abolished by 
culturing cells in the presence of antioxidants (Lee et al., 1999). Therefore, OIS 
appears to be engaged by a variety of intrinsic and extrinsic signals but is not clearly 
associated with telomere shortening (Hornsby, 2007). Independent of the mechanism, 
cells that have undergone OIS and replicative senescence share common features 
such as flat morphology, SA-β-Galactosidase activity and induction of cell cycle 
inhibitory proteins such as p53 and p16INK14 (Serrano et al., 1997; Ferbeyre et al., 
2002).   
 
2.3 The secretory phenotype of senescent cells 
 
Cellular reprogramming carried out during senescence results in stable blockage of cell 
cycle progression and in different morphology and function, as it has been mentioned 
before. However, the senescent phenotype is not limited to these alterations since 




medium of senescent cells, with a persistent DNA damage, is enriched with secreted 
proteins including growth factors (GM-CSF, G-CSF), inflammatory cytokines (IL-1α, IL-
1β, IL-6), chemokines (MCP-1, CXCL8) and extracellular proteases (MMP-3, MMP-10) 
(Shelton et al. 1999; Krtolica and Campisi 2002; Acosta et al. 2008; Coppé et al. 2008; 
Kuilman et al. 2008; Wajapeyee et al. 2008; Augert et al. 2009; Coppé et al., 2010).  
The specific secretory pattern of senescent cells, also demonstrated in vivo, has been 
denoted as “senescence associated secretory phenotype” (SASP) and entails changes 
in the released of >40 factors that exert a broad range of effects on the local tissue 
microenvironment (Coppé et al., 2008).  
Senescence develops gradually from an initiation point (DDR) to entirely senescent 
phenotype (irreversible growth arrest). In this sense, transitional phases define the 
establishment of senescence, which are largely unidentified with respect to kinetics and 
central mechanisms, including the effects produced by SASP factors (Passos et al. 
2010). The mechanisms that origin and sustain the SASP are uncertain.  Nevertheless, 
some studies reported that components of the SASP, such as IL-6 and IL-8, can 
maintain the senescence cell cycle arrest via an auto-regulatory feedback mechanism-
(Kuilman et al., 2008; Wajapeyee et al., 2008). Many of SASP factors can contribute to 
normal tissue repair. For example, it has been demonstrated that IL-6, IL-8, MMP, 
growth factors and proteases participate in wound healing, attractants for immune cells 
kill pathogens and stem or progenitor cells, communicating cellular 
damage/dysfunction to the surrounding tissue and if needed, stimulating repair (Coppé 
et al., 2008).  
The SASP inflammatory cytokines are of particular interest because they can play a 
role in much age-related pathologies (Campisi et al., 2008). IL-1α and IL-β are minor 
SASP components which, compared to IL-6 and IL-8, are secreted at low levels 
(McCarthy et al., 2008). IL-1 (α/β forms) is a multifunctional cytokine that regulates 
inflammatory and immune responses mainly by originating a signal transduction 
cascade which lastly induces IL-6 and IL-8 expression (McCarthy et al., 2008).  
The most important cytokine of the SASP is IL-6, a pleiotropic pro-inflammatory 
cytokine (Coppé et al., 2008). IL-6 secretion has been shown to increase markedly 
after DNA damage- and OIS senescence of mouse and human keratinocytes, 
melanocytes, monocytes, fibroblasts and epithelial cells (Kuilman et al., 2008). The 
senescence response, SASP in particular, may reduce health by stimulating both the 
inflammation associated with aging as well as the development of specific age-related 




Interestingly, this secretory phenotype seems to act as a double edged sword 
regarding tumor initiation and maintenance. It has been shown that the SASP can have 
pro-tumorigenic effects; for instance, it has been shown that senescent mesenchymal 
cells increase the tumorigenicity of nearby breast cancer cells (Freund et al., 2010). 
Likewise, it has been proposed that loss of proliferative competition of senescent cells 
can allow progression of leukemic cells during aging (Bilousova et al., 2005). 
Additionally, abnormal secretion of cytokines and growth factors by the SASP can 
accelerate this process in aged and chronically injured organ systems. However, the 
SASP also presents antitumor effects. It has been reported that in liver cancer mouse 
model the activation of p53 induces senescence, an up-regulation of inflammatory 
cytokines and stimulation of innate immune responses causing tumor cell clearance 
(Xue et al., 2007).  
 
2.4 Senescent cells biomarkers 
 
Although senescence can be induced by a wide spectrum of factors, senescent cells 
present specific characteristics that allow their identification in both in vitro and in vivo. 
These biomarkers reflect changes in morphology, gene expression, functionality, 
metabolism and, definitely, cell division (Kuilman et al., 2010). However, in order to 
correctly identify senescent cells, cells under study have to present several of these 
biomarkers, being essential an irreversible growth arrest. 
 
2.4.1 Cellular morphology 
 
Cell senescence is commonly accompanied by remarkably morphological alterations 
(see point 2.1) which depend on the specific senescence-induced factor (Kuilman et 
al., 2010). These modifications can range from produce multi-nucleation, to become 
cells large, flat, refractile or even generate extensive vacuolization as a result of 
endoplasmic reticulum stress caused by the unfolded protein response (Denoyelle et 
al., 2006). For example, Raf-dependent senescence normally originates a more 
spindle-shaped morphology (Chan et al. 2005; Michaloglou et al. 2005). In contrast, 
cells senescing due to Ras overexpression, persistent DDR or stress become flat 
(Chen and Ames, 1994; Serrano et al., 1997; Chen et al., 2001; Parrinello et al., 2003; 




growing cells with those suspected to be senescent can help to identify them as 
senescent cells. 
 
2.4.2 Telomeres length 
 
Telomere shortening has been associated with DNA damage-induced senescence 
process (see section 2.2). Telomere length test is a very easy measurement based on 
a specific controlled quantitative real time PCR (see point 8.4 from Material and 
Methods) that allow quantify the shortening of telomeres due to successive cell 
divisions and compare it with normal cells (Sebastián et al., 2009). 
 
2.4.3 Senescence-associated β-galactosidase (SA-β-gal) activity 
 
SA-β-gal activity is the most exploited marker in identifying senescent cells because of 
the simplicity of the assay method and its apparent specificity for senescent cells that 
can distinguish them from quiescent cells (Dimri et al., 1995). The technique is based 
on the observation that β-galactosidase activity measured at a suboptimal pH (pH 6.0) 
specifically stains senescent cells, while the same procedure carried on at pH 4.0 
uniformly stains all type of culture cells in vitro. SA-β-gal activity has been also 
detected in vivo in organs of old individuals, suggesting that cellular senescence is an 
aging mechanism of organisms where senescent cells accumulate in tissues (Campisi 
and D’Adda di Fagagna, 2007). Although it is unclear the function of SA-β-gal in 
senescence, it has been reported that this activity is due to the increase in lysosomal 
content in senescent cells (Dimri et al., 1995). 
 
2.4.4 Cell cycle progression  
 
Withdraw from the cell cycle is the only indispensable marker for the identification of all 
types of cellular senescence both in vitro and in vivo. However, quiescence and 
terminal differentiations share this particularity. Thus, the irreversible growth arrest 
cannot be used in isolation to detect senescent cells. 
Some studies have demonstrated that exist some conditions that allow escape from 




interleukins (Beausejour et al. 2003; Dirac and Bernards 2003; Coppé et al. 2008; 
Kuilman et al. 2008). Although it is a rare event in cultured cells, it is very relevant in 
vivo for cancer progression (Vredeveld and Peeper, unpubl.). Additionally, it has been 
shown that the reversibility depends on the expression of p16INK4A prior to entering 
senescence (Beausejour et al., 2003).  
 
2.4.5 DNA damage foci 
 
The detection of the MRN complex (localized in DSBs which induces the signaling 
pathway of the DDR, see section 2.2), has been suggested to be a cellular senescence 
biomarker (Lee et al., 2006). Similarly, the phosphorylation of H2AX (γ-H2AX), 
produced by DSBs which promote the assembly of the MRN complex and the 
subsequent signaling, is also a useful marker for senescence (Ben-Porath and 
Weinberg, 2004). 
 
2.4.6 Reactive oxygen species (ROS) 
 
Although oxidative stress certainly plays a key role in senescence since senescent 
cells present high levels of ROS (see point 2.2), how it increases and what the cellular 
targets are remains unclear (Lu and Finkel 2008). However, ROS production is easily 
measured and represents an important marker for identifying senescent cells. 
 
2.4.7 Apoptosis resistance  
 
It has been demonstrated that several, but not all, senescent cells show resistance to 
apoptosis upon apoptotic conditions comparing with young cells (Hampel et al., 2005). 
However, the underlying mechanism is poorly understood due to the complexity of 






2.5 Molecular mechanisms inducing cellular senescence 
 
p53 and pRb molecular pathways have been widely studied to investigate senescence 
mechanisms confirming their relevance in this process (Figure 6). 
 
p53 is a well-known protein important for the correct progression of the cell cycle since 
it maintains the genomic integrity. It has been demonstrated that mutations in the p53 
gene or dysfunctional p53 protein result in an uncontrolled cell division (Vogelstein et 
al., 2000). Moreover, p53-deficient mice present spontaneous tumors and in practically 
50% of all human cancer p53 does not work properly (Donehower et al., 1992; 
Donehower et al., 1995). 
 
p53 is activated under stress signals and induces cell cycle arrest, apoptosis or 
senescence. Some evidences suggest that high p53 activity drive to organismal aging 
regulating genes by transcriptional activation or proteins by direct binding (Murphy, et 
al., 1999; Guimaraes and Hainaut 2002). In addition, p21 is involved in the p53 tumor 
suppressor activity. In this sense, p53 activation causes upregulation of p21 which in 
turns is able to inhibit the activity of CDK-cyclin complexes blocking the cell cycle at 
different stages and inducing senescence (Gartel et al., 1996; Colman et al., 2000; 
Taylor and Stark 2001).  
pRb protein is ubiquitously expressed in all tissues and is regulated in a cell cycle-
dependent manner acting as a general regulator of cell cycle (Cobrinik et al., 1992). Its 
main function is to bind negatively to the E2F family of transcription factors in G1/S 
phase of the cell cycle in order to block the cell cycle progression (Morris and Dyson, 
2001). However, pRb is also critical for the senescence process. Although it has been 
difficult to obtain experimental data, it is believed that pRb is involved in the 
maintenance of the senescent state (Narita et al., 2003). pRb activity is also linked to 
p16INK4 function (Pavel et al., 2003). p16INK4 is a tumor suppressor whose main function 
consists in inactivate cyclin D-CDK complexes resulting in the inhibition of CDK4/CDK6 
that then is unable to phosphorylate pRb (Haller et al., 2002). Moreover, p16INK4 is 
considered as a senescence marker since is upregulated upon replicative senescence 
and is maintained at high level in senescent cells (Stein et al., 1999). 
Although p53/p21 and p16/pRB signaling pathways can act synergistically to induce 




(Magalhaes, 2004). However, they are not fully understood and downstream effectors 





Figure 6. Cellular senescence mechanisms. Although various stressors can undergo 
cellular senescence, the signaling induced converge mainly to two different pathways: p53 
and pRb whose activation provokes aging, tumor suppression and tissue repair. Adapted 




3. Cellular senescence and its role in aging  
 
Aging can be defined as the time-related deterioration of the physiological functions 
required for survival and fertility. The connection between aging and senescence 
processes has been studied intensively (Campisi et al., 2011; Schraml and Grillari, 
2012). Actually, senescent cells have been observed in mammals in association with 
aging.  In this sense, it has been demonstrated that the accumulation of senescent 
cells in vivo in various tissues, such as skin, liver, kidney or brain, is linked to altered 




In fact, it is not clear what happens to senescent cells in the body since they behavior 
depends on the cell type. For example, it has been demonstrated that senescent 
fibroblasts from mice are resistant to apoptotic stimuli while senescent endothelial cells 
are more sensitive (Wang, 1995; Hoffman et al., 2001). Another important point is the 
impact on the accumulation of senescent cells in the immune system response. It has 
been observed that senescence is characterized by the alteration in gene expression of 
some cytokines, chemokines and surface markers involved in inflammation (Yoon et 
al., 2004; Minamino and Komuro, 2007; Ren et al., 2009). Although these changes 
could induce senescent cells elimination, mainly by macrophages (Xue et al., 2007), it 
is required further investigations in different aging models as well as in human studies.   
The idea that senescence contributes to the development of the process of aging is 
rational but is still under debate owing to the controversial results obtained (Lorenzini et 
al., 2005; Patil et al., 2005). Some studies are in favor of a key role of senescence in 
the development of organismal aging and age-related pathologies. In this sense, it has 
been shown that senescent cells and their products (predominantly SASP derived 
molecules) induce the elderly phenotype. For instance, senescence in breast caused 
by deterioration of the structure or in altered migration and proliferation of cells caused 
by changed expression of extracellular matrix macromolecules (Campisi et al., 2011; 
Noureddine et al., 2011) is similar to skin aging or cognitive impairment (Alzheimer’s or 
Parkinson’s disease) produced by senescent cells (Bitto et al., 2010; Salminen et al., 
2011; Velarde et al., 2012).  
In addition, the role of senescent cells was confirmed in several age-related diseases, 
such as macular degeneration, COPD (Chronic Obstructive Pulmonary Disease), 
emphysema and insulin resistance (Campisi et al., 2011). However, due to the 
complexity of the process, it is unknown whether this increased number of senescent 
cells in tissues is the cause or the consequence to becoming older and whether it is 
good or bad for the organism. Therefore, the mechanism involved in the causal 
senescence-aging process has to be clarified. 
 
3.1 Aging, senescence and cancer 
 
The cellular response prompted by senescence inducing stimuli (short telomeres, DNA 
damage, overexpression of certain oncogenes and cellular stress, among others) is 




senescence (Serrano and Blasco, 2001; Ben-Porath and Weinberg, 2004; Colavitti and 
Finkel, 2005; Passos and Von Zglinicki, 2006), as it has been mentioned in section 2.5 
of this introduction.  
In the last years, it has become clear that the senescence response is a potent and an 
efficient cell autonomous tumor suppressive mechanism. In this regard, senescence 
inducing factors, such as DNA damage or stress, prevent the initiation of tumorigenesis 
(Dimri, 2005). Consistent with this data, the blockage of cell proliferation presented by 
senescent cells depends mainly on p53 and pRb pathways (Itahana et al., 2001; 
Ohtani et al., 2004), two of the most powerful tumor suppressor routes. Thus, genetic 
mutations or functional defects of the genes or proteins involved in these mechanisms 
favor the malignant transformation of cells preventing the bypass to the senescent 
phenotype. 
The tumor suppressive character of senescence seems to be clear, however, there are 
some investigations suggesting that the SASP could promote malignant phenotypes, 
even in vivo (Bavik et al., 2006; Coppé et al., 2006; Coppé et al., 2008). It has been 
shown that the SASP induces the cellular transition of epithelial to mesenchymal in 
culture, favoring the progress of invasive and metastatic carcinoma, due to the release 
of certain SASP components such as IL-6, IL-8 and GRO (growth related oncogene) 
(Krtolica et al., 2001; Roninson, 2002; Dilley et al., 2003).  
In addition, in mouse xenograft studies have been demonstrated that the secretion of 
MMPs produced by senescent cells induces tumor growth and invasiveness in vivo (Liu 
and Hornsby, 2007). Although these studies did not demonstrate a direct connection 
between SASP factors and the appearance of tumors, they support that SASP factors, 
released by senescent cells accumulated with age, can produce the conversion of 
neighboring premalignant cells to malignant (Hasty et al., 2003). 
 
3.2 Immunosenescence and Inflammaging in the macrophage lineage 
 
One of the most recognized effects of getting old is the dysregulation of the innate and 
adaptive immune function with advancing age (Figure 7), thus leading to increase 
susceptibility to viral and bacterial infections, reactivate latent viruses and decrease 




In fact, the aging alteration of the immune system results in defects in the initiation and 
in the resolution of immune responses, process called immunosenescence, and 
chronic low-grade inflammation, termed inflammaging. This chronic subclinical 
condition has been associated with increased mortality and major incidence of immune 
diseases and cancer in the elderly as well as an increased prevalence of metabolic 
syndrome, atherosclerosis and neurodegenerative diseases (Franceschi et al., 2007; 
Montecino-Rodriguez et al., 2013). 
 
 
Figure 7. Dysregulation of the innate immune system associated with aging and 
disease. Diminished innate immune responses are found in some cases such as the skin. 
However, other tissues present hyperactive innate immune system as the brain.  Adapted 
from Shaw et al., 2013. 
 
Deterioration of the innate immunity seems to be the established mechanism linked 
with age-related infections (Colonna-Romano et al., 2008), however, since innate 
immune activity is required to develop an appropriate adaptive immune response, age-
related deficits in innate immune functions might therefore change both cell-mediated 




Given the importance of macrophages to orchestrate the progression of the immune 
response (see section 1.3 of this introduction) deficiencies in macrophage activities 
associated with age, process known as MacrophAging (Sebastián et al., 2005), 
contribute significantly to the disorder of the immune responses observed in the elderly.  
For instance, some studies in humans and mice have demonstrated that TLR 
expression and function fail with age (Aspinall et al., 2007). This alteration reduces the 
production of normal levels of pro-inflammatory cytokines and chemokines causing the 
no activation of T and B cells and several processes involved in the adaptive immune 
system (Aspinall et al., 2007). On the contrary, Boehmer and co-workers reported that 
TLR expression is not affected by advanced age and explained the low levels of pro-
inflammatory cytokines by impaired intracellular signaling produced by reduced p38 
and JNK MAPKs phosphorylation (Boehmer et al., 2004).  
Furthermore, it has been shown that the reduced expression of MHC II of aged 
macrophages is connected with a declined T cells clonal expansion (Seth et al., 1990; 
Garg et al., 1996; Solana et al., 2006). In this sense, the elimination of pathogenic 
microorganisms by phagocytosis is also impaired in aged macrophages (Antonini et al., 
2001; Mancuso et al., 2001) as well as the chemotactic activity and the macrophage 
production of chemokines such as MIP-1α/β and MIP-2 (Ortega et al., 2000; Swift et 
al., 2001).  
All of these deficiencies are not only produced by reduced macrophage functions. The 
communication between the cells of the immune system and tissue cells seems to be 
impaired. For example, in aging the vascular endothelium decreased the expression of 
cell adhesion molecules (Ashcroft et al., 1998) and VEGF and EGF receptors (Ashcroft 
et al., 1997; Ashcroft et al., 2002).  
On the other hand, the progressive pro-inflammatory state shown in healthy-aged 
individuals, termed inflammaging, mentioned before, consists in a higher basal 
inflammatory state in the absence of an immune challenge. The elevated pro-
inflammatory circulating cytokines includes IL-6, TNF-α and IL-1β which can affect the 
phenotypes and functions of cells and cause susceptibility to a poor prognosis after 
systemic insults (Franceschi et al., 2000).  
There are many processes that can induce or contribute to inflammaging. 
Immunosenescence is one of them. Defective regulation of the complement pathway 
drives to local inflammation that in age can cause degenerative diseases (Gallenga et 




immunity, mainly macrophage functions, could result in hyperactivity to undertake the 
burden (Franceschi et al., 2000; McElhaney, 2009; Shaw et al., 2011). 
Persistent senescent cells can also induced inflammaging. Through the SASP, 
senescent cells can modify the tissue microenvironment and then the function of 
neighboring normal or premalignant cells (Campisi et al., 2007; Baker et al., 2011). 
Senescent cells are localized at sites of many age-related pathologies and it has been 
shown that their elimination in prematurely aged mice prevents several age-related 
pathologies (Coppé et al., 2010). 
Several molecules can be accumulated with age and act as endogenous damage, such 
as ATP, urate crystals and free radicals from oxidative stress, among others (Dall’Olio 
et al., 2013). These compounds can be recognized by the innate immunity through a 
network of sensors called inflammasomes that once activated can initiate an immune 
reaction required for physiological repair. As damage accumulates, this response can 
become chronic (Franceschi et al., 2000).  
Other source of inflammaging is represented by microbial constituents of the organism 
such as gut microbiota (Biagi et al., 2011). As gut presents an impaired physical 
function with aging and gut microbiota changes with aged, these “new” microbes or 
their products can escape from the gut and initiate an inflammatory response (Wikby et 
al., 2006; Larbi et al., 2008). 
However, it is still under study whether this low-grade of inflammation is pathogenic or 
adaptive. Chronic inflammation leads to tissue deterioration but is also part of normal 
tissue restoration. Centenarian healthy-individuals present systemic inflammation with 
high levels of IL-6, TNF-α and IL-8 in plasma but also a delay in the development of 
chronic aged-related diseases such as type II diabetes, cardiovascular disease and 
cancer (Varadhan et al., 2014). This fact suggests that inflammaging is compatible with 
health and longevity and proposes that there are others factors, not only high levels of 
pro-inflammatory cytokines, determinant for health or disease in the elderly. 
Given the easiness with which macrophages adapt to changes in their 
microenvironment, the evidence that aging modifies tissue milieu suggests that 
targeting aged-related factors might reestablish the correct macrophage function in the 
elderly.  Nevertheless, these factors are unknown and could be very abundant. It has 
been postulated that oxidative stress alters several transcription factors involved in the 




sense, the research into the effect of aging on macrophages is clearly needed in order 







































Aging has been associated with defects in immune function characterized mainly by 
decreased immune response to bacterial and viral infections, altered wound healing 
processes and dysregulated cytokines and chemokines secretion. The essential role of 
macrophages to coordinate innate and adaptive immune response to pathogenic 
insults and to maintain homeostasis led us to explore the effects of aging on senescent 
macrophages. In this sense, deficits in macrophage activity participate considerably to 
the altered immune responses observed in the elderly. 
 
The effects of aging on macrophages were addressed in two specific objectives: 
 
1. Characterization of a novel macrophage senescent model based on long-period 
cultures of BMDM. 
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1. Buffers and solutions  
Laboratory stock solutions and common buffers were prepared as described in 
weblink:http://onlinelibrary.wiley.com/doi/10.1002/0471143030.cba02as00/abstract., 
(Current Protocols in Cell Biology, 2001).  Buffers used in this thesis were specified 
below. 
Protein lysis buffer for Western Blot 
1 M HEPES-NaOH (7.5 pH), 0.5 M EGTA, 180 mM β-glycerophosphate, 1 M MgCl2, 
1% NP-40, 10 µg ml-1 Aprotinine,10 µg ml-1 Leupeptine, 1 mM DTT,1 mM PMSF,1 mM 
Orthovanadate and 30 µg ml-1  Iodoacetamide. 
Senescence-associated β galactosidase staining solution 
1 mg ml-1 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal), 5 mM K4(FeCN)6, 
5 mM K3Fe(CN)6, 2 mM MgCl2, 150 mM NaCl and citrate/phosphate buffer pH6 (0.1 M 
citric acid, 0.2 M Na2HPO4). 
FACS buffer 
PBS 1X, 2% Fetal Bovine Serum (FBS) and 0.1% NaN3. 
FACS fixed buffer 
PBS 1X, 2% Fetal Bovine Serum (FBS), 0.1% NaN3 and 2% paraformaldehyde. 
Griess reagent 
1% sulfanilamide, 0.1% N-(1-napthyl)ethyl-enediamine dihydrochloride (NED) and 
2.5% phosphoric acid. 
Arginase activity stop solution 
Acid solution mixture of H2SO4:H3PO4:H2O 1:3:7. 
Electrophoresis buffer (10X)  
30 g of Tris base  
10 g of SDS  
144 g of Glycine  
Dissolved in distilled water and bring volume up to 1 L.  
Transfer buffer (10X)  
30.3 g of Tris base  
1 g of SDS  
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144 g of Glycine  
Dissolved in distilled water and bring volume up to 1 L.  
20% methanol was added to 1X transfer buffer before use.  
Laemmli-SDS-PAGE gels  
Resolving gels (for 20ml)  
V (ml) 8% 12% 15% 
H2O 9.3 6.6 4.6 
30% Acrylamide solution 5.3 8 10 
1.5 M Tris (pH 8.8) 5 5 5 
10% SDS 0.2 0.2 0.2 
10% APS 0.2 0.2 0.2 
TEMED 0.008 0.008 0.008 
Proteins resolved NOS2, STAT3, STAT5  p38, JNK, ERK  IL-1β, p53, Ɣ-H2A, H1  
Stacking gels (for 5 ml)  
V (ml) 4% 
H2O 3.07 
30% Acrylamide solution 0.67 
1.5 M Tris (pH 8.8) 1.25 
10% SDS 0.05 
10% APS 0.05 
TEMED 0.005 
 
Laemmli sample loading buffer (5X)  
For 20 ml: 
4.5 ml of 1 M Tris pH 6.8  
11.5 ml of 87% glycerol  
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1 g of SDS  
1.5 ml of 1% Bromophenol blue  
0.8 g of DTT (154.25 g mol-1)  
Add up to 20 ml water and rotate on a wheel for 30 min. Store in aliquots at -20ºC.  
 
2.  Reagents 
 
All products used are summarized in Table 1 and and kits used in Table 2.  





Function Company Reference 
3
H-thymidine - Radioactive nucleoside Amersham  TRK300 
Actinomycin D Act.D Transcription inhibitor Sigma-Aldrich A-1410 
Adenosine triphosphate ATP P2x7R agonist Sigma-Aldrich A2383 
Bromodeoxyuridine  BrdU Nucleoside Sigma-Aldrich B5002 
Chloride acid HCl Inorganic acid Sigma-Aldrich 320331 
Citric acid - Organic acid Merck 244 
Cytochalasin D Cyt.D Phagocytosis inhibitor Sigma-Aldrich C8273 




Quantification of reactive 
oxygen species 
Sigma-Aldrich D6883 
Dimethylsulfoxide DMSO Solvent Sigma-Aldrich D8418 
Etoposide Etop. DNA damage inducer Tocris 1226 
Hydrogen Peroxide H2O2 ROS inducer Sigma-Aldrich H3410 
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Interleukin-4 IL-4 Macrophage activator RD SYSTEMS 404-ML-010 
L-arginine - aminoacid Sigma-Aldrich A5131 
Lipopolysaccharide LPS TLR4 agonist Sigma-Aldrich L3129 














Preparation of fixed 
samples 
Sigma-Aldrich P-6148 
Phosphoric acid H3PO4 Inorganic acid Fluka-Sigma 40779 
Potassium ferricyanide K4(FeCN)6 Inorganic salt Sigma-Aldrich P9387 
Potassium ferrocyanide K3Fe(CN)6 Inorganic salt Sigma-Aldrich B4252 
Propidium iodide PI 











rM-CSF Recombinat growth factor Merck  234378 
Sodium azide NaN3 Inorganic salt Sigma-Aldrich S2002 
Sodium chloride NaCl Inorganic salt Fluka-Sigma 71381 
Sodium Nitrite NaNO2 Inorganic salt Sigma-Aldrich S2252 
Sulfanilamide - 
Blockage of dihydrofolic 
acid synthesis 
Sigma-Aldrich S9251 
Sulfuric acid H2SO4 Inorganic acid Fluka-Sigma 84720 













determination of urea 
Sigma-Aldrich 13502 
Table 2. Detailed kits used. 
 
Kit Company Reference 
Annexin V kit BD Transduction 556547 
Genomic blood DNA purification kit GE Healthcare 27-9603-01 
IL-1β ELISA kit R&D Systems MLB00C 
Mouse Inflammation kit BD Biosciences 552364 
Purelink Dnase kit Invitrogen 12185-010 
Purelink RNA minikit Ambion 12183018A 
SOD activity kit Sigma-Aldrich 19160 
Super script II Reverse Transcriptase Invitrogen 18064-014 
 
 
3. Animal strains 
Bone Marrow-Derived Macrophages (BMDM) were obtained from different 8 week-old 
BALB/c mice which were purchased from Charles River Laboratories (Wilmington, MA). 
All animals were healthy, housed in a barrier system (temperature: 20-26ºC; relative 
humidity: 40-70%) with a 12 h light-dark cycle. Water and standard diet were available 
add libitum. Mice were killed by cervical dislocation and the animal use was approved 
by the Animal Research Committee from the University of Barcelona (number 2523). 
4. Generation of Bone Marrow-Derived Macrophages 
(BMDM) 
 
To obtain BMDM, mice were killed by cervical dislocation and bone marrow was 
flushed out of the femurs and tibias of adult mice in DMEM medium under aseptic 
conditions as was previously described (Celada et al., 1984). Cells were suspended by 
vigorous pipetting and cultured in plastic dishes of 150 cm2 (Miles Laboratories, Inc., 
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Naperville, IL) in complete medium consisting  on DMEM rich in glucose containing 
20% of FBS, 30% of L-cell conditioned media as a source of M-CSF (see point 6), 
using 4 plastic dishes and obtaining around 100.106 cells per mouse. Media was 
supplemented with 50 U ml-1 penicillin and 50 μg ml-1 streptomycin. Cells were 
incubated at 37 ºC in a humidified 5% CO2 atmosphere. Cells were grown to reach a 
state of subconfluence and after 7 days a homogeneous population was observed (0 
days BMDM), consisting of attached cells, positive for surface macrophage markers 
such as Cd11b and F4/80 (>90%).  
To obtain long-lasting cultures of macrophages (14 days BMDM), a normal mature 
culture of BMDM (0 days BMDM) was replated in 150 cm2 plastic dishes  (2x106 cells) 
in complete medium for 7 days. After this period of time, the macrophages obtained 
were replated again (5x106 cells) re-establishing the complete medium for 7 other days 
to get 25x106 of senescent macrophages per plastic dish. 
 
4.1 Macrophage cultures 
 
After 7 days of macrophage differentiation, BMDM were replated in plastic dishes 
(1x106 cells/24-well plates, 3x106 cells/ 60 mm) in order to perform different 
experiments. After adherence, BMDM were stimulated with different treatments. 
Treatments were always performed with rM-CSF (10 ng ml-1), rGM-CSF (5 ng ml-1), 
LPS (10 ng ml-1), IFN-γ (20 µg ml-1), IL-4 (10 ng ml-1), H2O2 (5 µg ml
-1) and Etoposide (1 
µg ml-1). ATP (1 mM) treatment was performed for the last 20 min of the indicated 
stimuli in order to prevent cell toxicity. DMSO was used as vehicle control when 
inhibitors used for treatments were dissolved in it. For RNA extraction, proliferation, cell 
cycle analysis and detection of phosphorylated proteins, BMDM were cultured in 
quiescent conditions (DMEM and 10% FBS) for 16 h before treatments in order to stop 
cell cycle. 
5. Cell line cultures 
 
5.1 L929 cell line 
 
L929 fibroblast cell line (ATCC CCL-1) was derived from normal subcutaneous 
areolar and adipose tissue of a 100-day-old male C3H/An mouse. NCTC clone 929 
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Clone of strain L was one of the first cell strains to be established in continuous 
culture, and clone 929 (also known as L929) was the first cloned strain developed. 
Clone 929 was established (by the capillary technique for single cell isolation) from 
the 95th subculture generation of the parent strain. These cells were cultured in 
tissue culture plates with high glucose DMEM supplemented with 10% fetal bovine 
serum (FBS) and cultured at 37°C and 5% CO2. 
5.2 J558L cell line 
 
J558L cell line (ATCC TIB-6) was derived from a BALB/c mouse plasmacytoma B 
lymphocyte. These cells were cultured in tissue culture plates with high glucose 
DMEM supplemented with 10% fetal bovine serum (FBS) and cultured at 37°C and 
5% CO2. 
 
5.3 MDA-MB-231 cell line  
 
The MDA-MB-231 breast cancer cell line (ATCC HTB-129) was obtained from a 
patient. With epithelial-like morphology, the MDA-MB-231 breast cancer cells 
appear phenotypically as spindle shaped cells. In vitro, the MDA-MB-231 cell line 
has an invasive phenotype. This MDA-MB-231/GFP cell line stably expresses GFP; 
the gene was introduced using lentivirus. These cells were cultured in tissue culture 
plates with high glucose DMEM supplemented with 10% fetal bovine serum (FBS) 
and cultured at 37°C and 5% CO2. 
 
6. Obtention of Macrophage-Colony Stimulating Factor (M-
CSF) supernatant 
 
Conditioned medium (L-cell) to generate macrophages from bone marrow was 
obtained from conditioned medium of the mouse fibroblast cell line L929 (see point 
5.1), which produces large quantities of M-CSF during proliferation. This is the only 
growth factor produced by these fibroblasts affecting macrophages. The addition of 
monoclonal antibodies against M-CSF to the medium blocks production of 
macrophages in culture (Lokeshwar and Lin 1988). 7x105 L929 cells were cultured in 
high glucose DMEM supplemented with 10% FBS at 37°C and 5% CO2. Cells were 
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growth in 150 mm flasks up to confluence and after 7 days the supernatant was 
collected, centrifuged to remove the cells in suspension and kept in aliquots at -80 ºC 
until the moment of use. Once thawed, the aliquots were stored at 4 ºC to prevent 
degradation of M-CSF resulting from freezing and thawing cycles. The content of M-
CSF was determined by a test of proliferation (3H-thymidine incorporation) in 
macrophages from mouse bone marrow. In our studies we use the concentration of 
30% of supernatant to differentiate bone marrow to macrophages which is equivalent to 
1200 U ml-1 of recombinant M-CSF (eBioscience, San Diego, CA), since this dose is 
able to saturate the M-CSF receptors on the surface of macrophages (Stanley, 1985). 
 
7.  Obtention of Granulocyte Macrophage-Colony Stimulating 
Factor (GM-CSF)   supernatant 
 
GM-CSF supernatant was obtained from conditioned medium of the mouse B myeloma 
cell line J558L (see point 5.2), which produces large quantities of GM-CSF during 
proliferation. This is the only growth factor produced by these cells affecting 
macrophages. 1x106 J558L cells were cultured in high glucose DMEM supplemented 
with 10% FBS at 37°C and 5% CO2. Cells were growth in 150 mm flasks up to 
confluence and after 5-7 days the supernatant was collected, centrifuged to remove the 
cells in suspension and kept in aliquots at -80 ºC until the moment of use. Once 
thawed, the aliquots were stored at 4 ºC to prevent degradation of GM-CSF resulting 
from freezing and thawing cycles. The content of GM-CSF was determined by a test of 
proliferation (3H-thymidine incorporation) in macrophages from mouse bone marrow. 
The concentration of 10% of supernatant is equivalent to 20 ng ml-1. 
 
8.  Experimental analysis 
 
8.1 RNA extraction from cultured cells 
 
3x106 quiescent BMDM (60 mm plastic dishes), were stimulated with different 
treatments. Total RNA from macrophage cultures were extracted using PureLinkTM 
RNA miniKit following manufacturer’s instructions (Ambion, Paisley, UK). 
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8.2 cDNA synthesis 
 
For cDNA synthesis, 1 µg RNA of each experimental sample was retrotranscribed with 
Superscript II Retrotranscriptase kit from Invitrogen, as described by the manufacturer 
(Carlsbad, CA). 
 
8.3 Quantitative real-time PCR (qRT-PCR) analysis  
 
For qRT-PCR analysis SYBR Green PCR Core Reagents and the ABI Prism 7900 
Detection System were used from Applied Biosystems (Arlington Heights, IL). The 
threshold cycle (CT) was defined as the cycle number at which the fluorescence 
corresponding to the amplified PCR product is detected. PCR arbitrary units (AU) were 
defined as the mRNA levels normalized to the housekeeping gene HPRT1 expression 
in each sample. The primer sequences are detailed in Table 3.  
Table 3. Primers used in qRT-PCR analysis. 
 
Gene Forward Sequence  5’------- 3’ Reverse Sequence  5’------- 3’ 
36B4 AGATGCAGCAGATCCGCAT GTTCTTGCCCATCAGCACC 
Arg-1 TTGCGAGACGTAGACCCTGG CAAAGCTCAGGTGAATCGGC 
b-actin ACTATTGGCAACGAGCGGTTC AAGGAAGGCTGGAAAAGAGCC 
Bcl-2 CGATGGTGTGGTTGCCTTATG GTCTACTTCCTCCGCAATGCTG 
Catalase AGCATATTGGAAAGAGGACCCC ATTTCACTGCAAACCCCCG 
Cdk2 CCATTCTCACCGTGTCCTTCA CCAAAGGCTCTTGCTAGTCCAA 
Cdk4 TGGAGCGTTGGCTGTATCTTT TGGAGGCAATCCAATGAGATC 
c-Myc AACAGCTTCGAAACTCTGGTGC CGCATCAGTTCTGTCAGAAGGA 
cycD1 TGCTGCAAATGGAACTGCTTC CATCCGCCTCTGGCATTTT 
cycE  GTTCACAGGAGGTTTGGCAAAA TGACCTCATCTGTGGTTCCAGG 
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E2F1 ATTGGTAAGCGGCTTGAAGG TTGCAGCTGTGTGGTACAGATG 
Fizz1 CCTTCTCATCTGCATCTCCCTG GCTGGATTGGCAAGAAGTTCC 
Hprt1 ATCATTATGCCGAGGATTTGG GCAAAGAACTTATAGCCCCC 
IA-b ACCCAGCCAAGATCAAAGTGC TGCTCCACGTGACAGGTGTAG 
il-10 TCCTTAATGCAGGACTTTAAGGG GGTCTTGGAGCTTATTAAAAT 
il-1β  TGGGCCTCAAAGGAAAGAAT CAGGCTTGTGCTCTGCTTGT 
Mgl-1 TGAGAAAGGCTTTAAGAACTGGG GACCACCTGTAGTGATGTGGG 
Mrc-1 AGATAATGGCCTCCGTTTGGTT TGCTGAGCTCTCCACAGGTG 
Nos2 GCCACCAACAATGGCAACA CGTACCGGATGAGCTGTGAATT 
p16 TGAATCTCCGCGAGGAAAGCGAAC CTGCTACGTGAACGTTGCCCATCA 
p21 CTGCTACGTGAACGTTGCCCATC CTGTGGGGTGAGGAGGAGCATGA 
p27 GGCCTTCGACGCCAGACGTAA CTTCACCCCCATGCTGACTCCTCA 
Raf AGGTGGTTGACCCAACTCCA TGCCGTGTTTTGCGC 
Sod1 AATGTGACTGCTGGAAAGGACG GCCAATGATGGAATGCTCTCC 
Sod2 TCTCTTTAGATCAGCGAAGCCC GGTCATCTCTGCCAAACTTGC 
Tgf-β TCGCCAGTCCCCCAAGCCAG CAGCAATGGGGGTTCGGGCA 
Tnf-α CCAGACCCTCACACTCAGATC CACTTGGTGGTTTGCTACGAC 
 
8.4 Telomere length quantification by real-time PCR 
 
3x106 unstimulated BMDM were replated in 60 mm plastic dishes. Telomere length was 
analyzed as described (Sebastián et al., 2009). Briefly, genomic DNA was isolated 
using the GFX genomic blood DNA purification kit from Amershan Biosciences 
(Buckinghamshire, UK), and real time PCR was performed as in RNA expression 
analysis using 35 ng of DNA/well. Telomere length was calculated as the ratio of 
telomere repeat copy number to single copy gene (36B4) copy number (T/S ratio). This 
ratio should be proportional to the average telomere length. To confirm that the number 
of copies of the single copy gene per cell that was effectively PCR-amplified was the 
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same in all samples being studied, we quantified the relative ratio of 36B4 copies to b-
actin copies. This ratio was = 1.0, indicating that equal copy numbers of 36B4 per cell 
were amplified in all DNA samples. Primer sequences (Table 3) and real-time 
conditions for telomere amplification were as described (Sebastián et al., 2009): 95ºC 
for 5 min, followed by 40 cycles of 95ºC for 15 sec and 60ºC for 1 min. 
 
8.5 Determination of protein concentration  
 
Total protein was quantified using Bradford assay according to manufacturer 
instructions (Sigma-Aldrich). Protein concentrations were measured with a 
spectrophotometer at an absorbance of 570 nm. For the calculation of protein 
concentrations a BSA-standard curve was used. 
 
8.6 Western blotting  
 
Proteins from treated macrophages were extracted using lysis buffer for western blot 
analysis (see point 1). Samples were centrifuged at 13.000 rpm for 20 min at 4ºC and 
the supernatant protein concentrations were measured by Bradford assay. In the case 
of IL-1β and NOS2, 20 μg of protein was used and resolved by SDS-PAGE. For P-p53 
P-p38, P-JNK, P-ERK1/2, P-STAT3, P-STAT5 and Ɣ-H2AX western blots, 
macrophages were cultured in quiescent conditions (90% DMEM and 10% FBS) for 16-
18 h. Then, cells were treated as indicated and 40 µg of total protein from cell lysates 
were resolved by SDS-PAGE.  After transference using a semi-dry transfer system, 
nitrocellulose membranes were blocked with 5% milk in TBS-0.1%Tween and 
incubated with primary antibodies overnight at 4ºC. After three washes, membranes 
were incubated for 1 h with fluorescent dye-labeled or peroxidase-conjugated anti-
rabbit or anti-mouse IgG. Enhanced fluorescence detection was then performed using 
Odyssey Classic System (Li-cor Biosciences, Lincoln, NE) or using ECL from Thermo 
Scientific (Rockford, IL) with x-ray films. -actin and H1 antibodies were used as 
loading control. 
In Table 4 the information of all antibodies used for western blotting in this Thesis is 
summarized. 
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 Table 4. Primary and secondary antibodies used for western blotting. 
 
Primary antibody Company Reference 
Ɣ-H2AX Millipore 05-636 
H1 Santa Cruz sc-10806 
IL-1β Abcam ab9722 
NOS2 Santa Cruz sc-8017 
P-ERK Cell Signal 9101 
P-JNK Cell Signal 9912 
P-p38 Cell Signal 9211S 
P-p53 Cell Signal 9284 
P-STAT3 Cell Signal 4904P 
P-STAT5 Cell Signal 9351S 
STAT5 R&D Systems PA-ST5A 
β-actin Sigma A5441 
 
 
Secondary antibody Company Reference 
Mouse IgG (Alexa Fluor 680) Invitrogen   A21057 
Mouse IgG (Alexa Fluor 800)  Rockland 610-731-124  
Rabbit IgG (Alexa Fluor 680) Invitrogen    A21076 
Rabbit IgG (Alexa Fluor 800) Rockland   611-131-122 
Rabbit IgG peroxidase-conjugated  Jackson 111-035-003 
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8.7 Protein surface expression 
 
Surface expression of Mac1 (Cd11b), MHC II (I-Aβ) and TLRs were analyzed with 
monoclonal anti-mouse antibodies, as described previously (Goñalons et al., 1998). 
1x106 BMDM were activated with IFN-γ (20 µg ml-1) for 48 h or LPS (10 ng ml-1) for 24 
h at 37ºC. Then, macrophages were collected and washed in ice-cold PBS 1X. 
Macrophages were resuspended in 100 μl FACS Buffer (see point 1) and then 
incubated on ice for 30 minutes with anti-CD16/CD32 mAb (1 µg ml-1) to block Fc 
receptors. They were then incubated for 30 minutes on ice with the specific FITC-
conjugated or PE-conjugated primary antibody (see Table 5) and washed by 
centrifugation through PBS 1X at 4°C, avoiding light. Finally, samples were fixing with 
FACS fixed buffer (see point 1). Stained cell suspensions were analyzed using an 
FC500 flow cytometer (Coulter Corp., Hialeah, FL). The parameters used to select cell 
populations for analysis were forward and side light scatter. As a control for specificity, 
we used an irrelevant antibody of the same isotype. 
 
Table 5. List of antibodies used for surface protein expression. 
 
Primary antibody Company Reference 
Cd11b-PE BD Pharmingen 557397 
CD16/CD32 BD Pharmingen 553142 
I-Aβ-FITC BD Pharmingen 553623 
TLR2-FITC Invivogen mab-mtlr2f 
TLR4-FITC Invivogen mab-mtlr4md2f 
TLR5-FITC Invivogen mab-mtlr5md2f 
TLR9-FITC Invivogen mab-mtlr9md2f 
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8.8 Cytokine determination 
 
Supernatants from BMDM were analyzed for IL-1β production by ELISA and for IL-12, 
IL-10 and TNF-α production by Mouse Inflammation kit, a cytometric bead array. 
Macrophages were treated with the indicated stimuli in 24 micro-well plates (106 cells 
well-1) for 24 h. Supernatants from these experiments were obtained and centrifuged at 
7000 rpm. The supernatants were frozen at -80ºC until cytokine determination. The 
user’s manual instructions were followed for the IL-1β immunoassay kit (R&D Systems, 
Minneapolis, MN) and for the Mouse Inflammation kit (BD biosciences). Cytometric 
bead array samples were analyzed using an FC500 flow cytometer (Coulter Corp., 
Hialeah, FL) and FCAP array software. 
 
8.9 Cellular counting of proliferating cells 
 
Macrophage number was analyzed by cellular counting. BMDM were deprived of M-
CSF for 16-18 h. Then, macrophages (3x102 cells µl-1) were replated in 60 mm plastic 
dishes and incubated at 37ºC in the presence of different percentages of specific 
growth factors supernatants (M-CSF or GM-CSF) for 24 h. Stimulated macrophages 
were washed with PBS 1X and incubated with trypsin for 5 min at 37ºC, centrifuged at 
1500 rpm for 5 min and resuspended in 500 μl of PBS 1X. Number of cells was 
determined using a Neubauer chamber. 
 
 
8.10 Analysis of DNA content with propidium iodide (PI) 
 
Cell cycle was analyzed as described (Xaus et al., 1999). 5x105 of quiescent BMDM 
were stimulated for 24 h with rM-CSF (10 ng ml-1) or rGM-CSF (5 ng ml-1). Then, 
macrophages were collected and fixed with EtOH 95% and incubated with propidium 
iodide (0.2 µg ml-1). Immediately, samples were analyzed by XL-Coulter flow cytometer 
and cell cycle distributions were determined with the Multicycle program (Watson, Flow 
Jo).  
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8.11 Proliferation assay 
 
Macrophage proliferation was measured by 3H-thymidine incorporation as described 
(Sebastián et al., 2009). BMDM were deprived of M-CSF for 16-18 h. Then, 
macrophages (105 cells well-1) were replated in 24 micro-well plates and incubated for 
24 h in the presence of different percentages of specific growth factors supernatants 
(M-CSF or GM-CSF). After this period of time, the medium was removed and replaced 
with media containing 3H-thymidine (1 μCi ml-1). After two additional h of incubation at 
37°C, the medium was removed and the cells were fixed in ice-cold 70% methanol. 
After three washes in ice-cold 10% TCA, the cells were solubilized in 1% SDS, 0.3 N 
NaOH. Radioactivity was counted by liquid scintillation using a 1500 Packard Tri-Carb 
scintillation counter (Meriden, CT) and expressed in cpm (counts per minute). 
 
8.12 BrdU labeling of proliferating cells 
 
Macrophage proliferation was also measured by BrdU incorporation. BMDM were 
deprived of M-CSF for 16-18 h. Then, macrophages (105 cells well-1) were replated in 
60 mm plastic dishes and incubated for 24 h in the presence of rM-CSF (10 ng ml-1) or 
rGM-CSF (5 ng ml-1). After this period of time, BrdU (10 µg ml-1) was added to the 
medium for 2 h at 37ºC. Then, macrophages were washed with PBS 1X, resuspended 
with FACS buffer (see point 1) and blocked with anti-CD16/CD32 mAb (1 µg ml-1) for 
30 min on ice. After 3 washes with FACS buffer, macrophages were incubated with 10 
µl of BrdU-FITC antibody (BD Biosciences, 556028) for 1 h on ice.  Then, the stained 
was fixed with FACS fixed buffer (see point 1) and samples were analyzed by flow 
cytometry using FC500 cytometer (Beckman Coulter, Inc., Pasadena, CA). FlowJo 
software was used to analyze data that was represented as BrdU fluorescence 
intensity. 
 
8.13 Apoptosis assay 
 
Apoptosis was measured using a fluorescent Annexin-V kit (Santa Cruz, CA).  
Macrophages (3-5x105 cells well-1) were stimulated with rM-CSF (10 ng ml-1), rGM-CSF 
(5 ng ml-1) for 24 h, Etoposide (1 µg ml-1) for 1 h, H2O2 (5 µg ml
-1) for 10 min or 
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actinomycin D (5 μg ml-1) for 12 h.  Stimulated macrophages were washed with PBS 
1X and incubated with trypsin for 5 min at 37ºC, centrifuged at 1500 rpm for 5 min and 
resuspended in 500 μl annexin-V binding buffer. Just before measurement, Annexin-V 
(25 μM) and propidium iodide (0.2 μg ml-1) were added for 10 min. Samples were 
analyzed by flow cytometry using FC500 cytometer (Beckman Coulter, Inc., Pasadena, 
CA). FlowJo software was used to analyze data that was represented as % of Annexin-
V and PI positive cells.  
 
8.14 Senescence-associated β-galactosidase activity staining (SA-βgal  
staining) 
 
SA-βgal staining is a cytochemical assay based on production of a blue-dyed 
precipitate that results from the cleavage of the chromogenic substrate X-Gal. Thus, it 
measures the enzymatic activity to hydralyze β-galactosides into monosaccharides 
carried out in a suboptimal pH (pH6) in which only senescent cells develop staining. 
106 unstimulated BMDM were replated on slideflasks. After adherence, macrophages 
were washed with PBS 1X; fixed in paraformaldehid 3% for 5 minutes and incubated 
with SA-β-gal staining solution (see point 1) for 18 h at 37ºC. Then, staining solution 
was eliminated with 3 washes of PBS 1X and 20% glycerol was added to the cells. 
Images were obtained through an inverted microscope (Nikon TE200+Olympus DP72 
PSA1). 
 
8.15 Analysis of macrophage ROS production 
 
Reactive oxygen species (ROS) levels were determined by FACS analysis. Quiescent 
BMDM (5.105 well-1) were replated in 60 mm plastic dishes. After adherence, 
macrophages were stimulated in the presence or absence of NAC (2 mM) with rM-CSF 
(10 ng ml-1), rGM-CSF (5 ng ml-1), LPS (10 ng ml-1) for 24 h or H2O2 (5 µg ml
-1) for 10 
min. After this period of time, BMDM were treated with the probe DCF-DA (25 μM) for 
20 minutes at 37ºC, avoiding light. Then, macrophages were collected and washed 
with PBS 1X. Immediately, fluorescence intensity was analyzed using FC-500 flow 
cytometer (Coulter) and represented as arbitrary units (AU) as previously described 
(Sebastian et al., 2009). 




8.16 Superoxide dismutase (SOD) activity measurement 
 
SOD, which catalyzes the dismutation of the superoxide anion (O2
-) into hydrogen 
peroxide and molecular oxygen, is one of the most important antioxidative enzymes. 
The determination of the enzymatic activity was measured using a specific indirect 
process based on colorimetric method.  Macrophages were treated with the indicated 
stimuli in 24 micro-well plates (106 cells well-1) for 24 h. Supernatants from BMDM were 
obtained and centrifuged at 7000 rpm. The user’s manual instructions were followed for 
SOD activity assay kit (Sigma-Aldrich) and represented as SOD activity percentage. 
 
8.17 Analysis of macrophage NO production  
 
NO production was measured by a colorimetric method based on the reaction of the 
Griess reagent. This system detects nitrite (NO2
–) which is a stable and nonvolatile 
breakdown product of nitric oxide (NO). BMDM were replated in 96 micro-well plates 
(104 cells well-1) in complete medium and stimulated with IFN-γ (20 µg ml-1) and/or LPS 
(10 ng ml-1) for 24 h at 37ºC. After this period of time, 100 μl of supernatant sample 
was mixed with 100 μl of Griess reagent (see point 1), avoiding light. After waiting 10 
min, optical density at 540 nm was measured and expressed as production of NO μM. 
Standard curve was used with different concentrations of NaNO2 (μM).  
 
8.18 Analysis of macrophage arginase activity  
 
Arginase activity was measured by a colorimetric method, as previously described 
(Classen et al., 2009). In this assay, arginase reacts with L-arginine and undergoes a 
series of reactions to form an intermediate that generates the colored product. BMDM 
were replated in 96 micro-well plates (104 cells well-1) in complete medium and 
stimulated with IL-4 (10 ng ml-1) for 24 h at 37ºC. After this period of time, 
macrophages were washed with PBS 1X and 100 µl of Triton x-100 (0.1%), 100 µl of 
Tris-HCl (50 mM, pH7.5) and 10 µl of MnCl2 (10 mM) were added. 100 µl of this 
mixture was incubated at 56ºC for 7 min and 100 µl of L-arginine (0.5 M, pH9.7) was 
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added. Then, samples were incubated at 37ºC for 1 h. After that, the reaction was 
stopped with 800 µl of arginase activity stop solution (see point 1). Then, 40 µl of α-
ISPP (6% in EtOH) was added in each sample. Finally, samples were incubated first at 
95ºC for 30 min and at 4ºC for also 30 min. Standard curve was used with different 
concentrations of urea and arginase activity was measured at 540 nm and expressed 
as mU. 
 
8.19 Phagocytosis of apoptotic cells  
 
The phagocytic activity of macrophages was measured by flow cytometry and by 
fluorescent microscopy. MDA-MB-231/GFP cells (see point 5.3) were treated with 
actinomycin D (5 μg ml-1) for 6 h to induce apoptosis. After this period of time, these 
cells were washed 3 times with PBS 1X and added to 105 BMDM, which were replated 
in 60 mm of plastic dishes (for cytometric analysis)  or in slideflasks (for microscopy 
analysis), in a proportion of 10:1 (10 apoptotic cells per one macrophage) with the 
presence or absence of a pre-stimulation of cytochalasin D (2 μg ml-1). After 1 h of 
incubation at 37ºC, BMDM were washed with PBS 1X. For flow cytometry 
measurement BMDM were resuspended in FACS buffer and samples were analyzed 
using a FC500 flow cytometer (Coulter Corp., Hialeah, FL). The parameters used to 
select cell populations for analysis were forward and side light scatter. For phagocytic 
images, after washed BMDM with PBS 1X, 20% glycerol was added to the cells.  All 
pictures were acquired with a fluorescent inverted microscope (Leica Nikon 
TE200+Olympus DP72 PSA1). 
 
9.  Statistical analysis 
 
The results shown correspond to at least 3 independent experiments, each experiment 
performed in triplicate, unless otherwise indicated in the figure legend. Data are 
expressed as the average ±SD (n≥9). The two-tailed t-test of the indicated groups was 
applied and significance of each particular group comparison was represented as “*” 






























Characterization of a novel 
macrophage senescent model based 









Macrophages are key cells in innate and adaptive immune functions. These cells may 
act directly, by destroying bacteria, parasites, viruses and tumor cells, or indirectly, by 
releasing mediators such as IL-1, TNF-α, etc, which can regulate other cells. 
Macrophages are also responsible for processing antigens and presenting digested 
peptides to T lymphocytes, and for tissue damage repair.  
Macrophage functions are altered in old age in humans, mice and rats, thereby 
contributing to the immunosenescence of adaptive and innate immunity. For instance, 
these cells acquire increased adhesion to the extracellular matrix and a flattened and 
much enlarged phenotype with a vacuolated morphology (Chang, Broude et al., 1999; 
Serrano and Blasco, 2001; Narita et al., 2003). Phagocytic activity, cytokine and 
chemokine secretion, antibacterial defenses such as the production of reactive oxygen 
and nitrogen intermediates, infiltration and wound repair functions in the late phase of 
inflammatory response, and antigen presentation are also altered in aged 
macrophages (Herrero et al., 2002; Sebastián et al., 2009). 
 
Bone-marrow derived macrophages (BMDM) cellular model is a homogeneous primary 
culture able to respond physiologically to differentiation, proliferation and activation. In 
addition, the easy way of isolate these cells makes it the most used model to study 
particular activities of macrophage biology, including aging (Herrero et al., 2002; 
Sebastián et al., 2009; Shaik-Dasthagirisaheb et al., 2010; Barrett et al., 2015). For 
these reasons, BMDM were selected as the cellular model to be used in our studies. 
Since cellular senescence has been associated with aging, we have compared 
characteristics of normal macrophage cultures (0 days macrophages) and long-period 
macrophage cultures (14 days macrophages) of BMDM to study the aging process of 
macrophages avoiding use aged mice. 
 
Long-term cultures of BMDM display a senescent phenotype 
Macrophages require the presence of growth factors, such as M-CSF or GM-CSF to 
proliferate and survive (Lacey et al., 2012). The stimulation of starved macrophages 
(macrophages deprived of M-CSF for 16 h) with different percentages of conditioned 
media of both growth factors induced the incorporation of radioactive 3H-thymidine in 
the cellular DNA. M-CSF supernatant produced high levels of macrophage proliferation 




able to increase macrophage proliferation probably because M-CSF receptors were 
saturated.  
In the case of GM-CSF, the proliferation rate induced by this growth factor was not so 
elevated in comparison with radioactive levels produced by M-CSF stimulation (Figure 
8A and B). However, GM-CSF was able to induce macrophage proliferation at very low 
concentrations (from 0.25%, being maximal at 0.5% of GM-CSF supernatant) and 
decreased at higher doses (5%) (Figure 8B). Consistently, recombinant M-CSF and 
GM-CSF were able to produce cell cycle progression from G1 phase observed in 
control macrophages (starved BMDM) to G2/M phase of the cell cycle (Figure 8C).  
As we expected, these facts indicate that macrophages obtained from mice bone-
marrow respond to conditioned media and recombinant M-CSF and GM-CSF which 
induced the activation of cell cycle and proliferation.  
 
Figure 8. BMDM proliferate in response to specific growth factors, M-CSF and GM-
CSF. (A and B) Starved BMDM were stimulated with different percentages of M-CSF (%) 
and GM-CSF (%) conditioned medium for 24 h. Proliferation induced by these growth 
factors was determined by 
3
H-thymidine incorporation. Radioactivity was expressed in 
cpm (counts per minute). (C) Starved BMDM were treated with recombinant M-CSF (10 
ng ml
-1
) or GM-CSF (5 ng ml
-1
) for 24 h. After this period of time, DNA content was 
determined by flow cytometry using propidium iodide (PI) staining. Each point was 
analyzed in triplicate and the results are shown as mean ± SD. All assays are 
representative for at least 3 independent experiments. **p<0.01 corresponds to the 




In order to investigate macrophage aging through cellular senescence process, we 
designed a culture procedure to achieve senescent macrophages (long-period BMDM) 
from a mature culture of young cells.   
For this purpose, once bone-marrow differentiated to BMDM (0 days BMDM, see 
section 4 of Material and Methods), 2.106 macrophages were replated in renewal 
complete medium (30% M-CSF and 20% FBS) for 7 days, obtaining a primary culture 
of 7 days BMDM. After this period of time, 5.106 of 7 days BMDM were replated again 
re-establishing the complete medium for 7 days more to get long-lasting cultures of 
macrophages termed 14 days BMDM (Figure 9A). To compare biological functions and 
cellular characteristics related to senescence and aging, we elaborate this method 
considering getting these different macrophage cultures simultaneously to perform the 
experimental analysis properly, planning the sacrifice of the mice every 7 days 
consecutively. 
Once these long-term cultures of macrophages were obtained, we decided to 
investigate if they presented senescent features. It is well known that senescence is 
associated with a permanent reduction of the proliferative capacity of cells (Chen, 
2007). Therefore, we decided to measure it in response to M-CSF and GM-CSF after 
starvation conditions. As we expected, while 0 days BMDM presented normal levels of 
thymidine incorporation, macrophages from long-term cultures showed a reduced 
proliferative capacity in both M-CSF- and GM-CSF-induced proliferation (Figure 9B).  
Although, GM-CSF-dependent macrophage proliferation was similar between 7 and 14 
days BMDM cultures, the reduction of the M-CSF proliferative capacity in 14 days 
BMDM was more important than in 7 days BMDM (Figure 9B). Thus, we decided to 
compare normal macrophages (0 days BMDM) with 14 days BMDM, using these cells 
as long-period cultures of macrophages for experimental analysis. 
In addition, to discard that this culture method modified phenotypical features of 
macrophages, we demonstrated that these long-period cultures are ordinary BMDM, 
but with a restricted capacity of multiplying, through forward and side scatter analysis 
as well as the measurement of surface expression of Cd11b, a well-known 
macrophage marker (Xu and Gordon, 2003). In this sense, cellular size and complexity 
of 14 days BMDM population were exactly the same as normal macrophages (Figure 
10A). Similarly, the fluorescence intensity of Cd11b staining in both cultures was high 




These results indicate that, although long-lasting BMDM cultures present an impaired 
proliferative capacity in response to two specific macrophage growth factors, they still 
have phenotypical macrophage characteristics. 
 
 
Figure 9. Long-term cultures of BMDM present a reduced proliferative capacity in 
response to M-CSF and GM-CSF. (A) Schematic representation of normal and long-
period BMDM cultures obtention to perform experimental analysis. (B) Starved BMDM 
were stimulated with different percentages of M-CSF (%) and GM-CSF (%) conditioned 
medium for 24 h. Proliferation induced by these growth factors was determined by 
3
H-
thymidine incorporation. Radioactivity was expressed in cpm (counts per minute). Each 
point was analyzed in triplicate and the results are shown as mean ± SD. All assays are 
representative for at least 3 independent experiments.  **p<0.01 corresponds to the 
statistical significance between indicated pair comparisons. 

































































Figure 10. Characterization of normal and long-term BMDM obtained from in vitro 
differentiation of bone marrow cells in mice. (A and B) 10
5
 BMDM from normal and 
long-lasting cultures were collected and analyzed by flow cytometry. (A)  Granularity and 
cell surface were detected by side scatter and forward scatter measurements. (B) Cd11b 
surface expression was analyzed by anti-Cd11b staining, as previously described in 
material and methods. All assays are representative for at least 3 independent 
experiments.   
 
While cellular senescence is induced by a wide variety of conditions, senescent cells 
display a number of characteristics that allow their identification (Kuilman et al., 2008). 
Some of these biomarkers reflect the activation of mechanisms that contribute to the 
senescence program, but others are the consequence of this process induction 
(Campisi and D’Adda di Fagagna, 2007).  
Cellular senescence is generally accompanied by morphological changes, which may 
be quite striking. Depending on the cell type, cells can become large, flat, 
multinucleated and even refractile (Hou et al., 2013; Biran et al., 2015).  In the case of 
macrophages we observed that un-stimulated 14 days BMDM seemed to be bigger 
and rounder comparing with cells from normal cultures (Figure 11, above images).  





























In addition, long-term cultures of macrophages were positive for the senescence-
associated β-galactosidase (SA-β-gal) activity specific staining (Figure 11, bottom 
images). This enzymatic activity increases in senescent cells due to an expansion of 
the lysosomal compartment, giving rise an increase in its activity that can be detected 
at a suboptimal pH 6 (Kuilman et al., 2008).  
 
 
Figure 11. Long-lasting cultures of macrophages show an increased β-
galactosidase activity.  10
6
 BMDM from normal and long-lasting cultures were 
incubated in the presence of the SA-β-gal staining solution for 18 h at 37 ºC, as it was 
indicated in Material and Methods section. Specific staining for senescent cells were 
performed based on the activity of β-galactosidase in a suboptimal pH. Bottom pictures 
correspond to the same image but with contrast phase. An inverted microscope was 
used to obtain images. This assay is representative for at least 3 independent 
experiments.   
 
Another important senescent biomarker is the telomere shortening (Rodier et al., 
2011). Telomeres are chromatin structures that cap and protect the end of 
chromosomes. Telomere loss has been shown in several cell types during aging but in 
particular, cells of the immune system are highly susceptible to telomere attrition 
because of their high proliferative potential (Sebastián et al., 2009). During aging in 
vitro, the telomeres shorten at each subcultivation and for this reason we purposed to 
analyze the telomere length in long-term macrophage cultures.  















In this sense, telomeres length was measured by real-time PCR and 14 days BMDM 
presented shorter telomeres than those from normal macrophage cultures (Figure 
12A). 
When telomeres reach a critical minimal length, their protective structure is disrupted 
and triggers a DNA damage response (DDR), which is associated with the activation of 
γ-H2AX, a phosphorylated form of the histone variant H2AX (d’Adda di Fagagna, 2003; 
Takai et al., 2003; Herbig et al., 2004; Rodier et al., 2009). 14 days BMDM stimulated 
with M-CSF and GM-CSF for 24 h increased γ-H2AX levels, indicating that these cells 
presented high levels of DNA damage comparing with normal BMDM (Figure 12B).   
 
 
Figure 12. Long-lasting cultures of BMDM show shorter telomeres and higher 
levels of DNA damage.  (A) Telomere length was measured by real-time PCR in normal 
and 14 days macrophages. The ratio of relative telomere to single copy gene (36B4) 
amplification (T/S) was shown by two independent experiments. (B) Starved BMDM were 
treated with recombinant M-CSF (10 ng ml
-1
) or GM-CSF (5 ng ml
-1
) for 24 h and DNA 
damage was determined by γ-H2AX immunoblotting. H1 image was used as loading 
control for western blots.  Each point was analyzed in triplicate and the results are shown 
as mean ± SD. All assays are representative for at least 3 independent experiments. 




































An important mechanism that leads to a wide spectrum of intracellular damage during 
aging is extended exposure to reactive oxygen species (ROS) generated by cellular 
metabolism (Kregel and Zhang, 2007). The formation and accumulation of ROS and 
free radicals affect DNA stability and other cellular elements (Blander et al., 2003; 
Langen et al., 2003; Ramsey and Sharpless, 2006). Therefore, ROS contributes to the 
senescence process inducing a DDR (Serrano et al., 2007).  
Consequently, we analyzed intracellular levels of ROS in starvation (basal), growing 
(M-CSF or GM-CSF) and activating conditions (LPS). Normal BMDM increased ROS 
levels after hydrogen peroxide (H2O2, positive control) and LPS treatments (Figure 
13A), while M-CSF and GM-CSF stimulations did not modify ROS quantities from basal 
conditions (Figure 13A).  In addition, the pre-treatment with a general antioxidant, N-
acetylcisteine (NAC), reduced ROS, indicating the specificity of the technique. After 
treatment, 14 days BMDM showed higher ROS levels even in basal and growing 
conditions in comparison with normal macrophages (Figure 13B), suggesting an 
increased oxidative stress in long-lasting BMDM cultures. 
Cells protect themselves from ROS metabolizing H2O2 and oxygen free radicals 
through different mechanisms. One of them is to convert these dangerous molecules 
into less-reactive substances through the enzymatic activity of catalase, superoxide 
dismutase (SOD1 and SOD2) and glutathione peroxidase (Zhao et al., 2008). Catalase 
reacts with the hydrogen peroxide to catalyze the formation of water and oxygen; 
SOD1 and SOD2 catalyze the dismutation of the superoxide ion into oxygen and 
hydrogen peroxide and glutathione peroxidase reduces hydrogen peroxide by 
transferring the energy of the reactive peroxides to a very small sulfur-containing 
protein called glutathione (Rampsey and Sharpless, 2006). 
As 14 days BMDM showed high levels of ROS, we evaluated the gene expression of 
some senescence markers involved in oxidative stress (Kuilman et al., 2008). It has 
been observed that antioxidant enzymes gene expression such as catalase, SOD1 and 
SOD2 is elevated in senescent cells although their activity is impaired (Haan et al., 
1996).  
In this sense, starved macrophages from normal and long-term cultures were 
stimulated with M-CSF and GM-CSF for the times indicated and mRNA levels of these 
enzymes were measured through qRT-PCR. M-CSF and GM-CSF treatments induced 
the overexpression of catalase and SOD2, but not SOD1, in macrophages from long-




SOD activity was impaired in these macrophages at growing and activating conditions 
(Figure 14D) preventing the elimination of free superoxide radicals.  
This data suggests that the reduction of SOD activity presented in 14 days BMDM 
probably contributes to the accumulation of ROS in macrophages which produduces 
DNA damage and, therefore, the induction of cellular senescence. 
 
 
Figure 13. Long-lasting cultures of BMDM present an increased oxidative stress.  
(A and B) Intracellular ROS levels were analyzed by FACS using DCF-DA staining in 
macrophages stimulated in the presence or absence of NAC (2 mM) with recombinant 
M-CSF (10 ng ml
-1
), GM-CSF (5 ng ml
-1
), LPS (10 ng ml
-1
) for 24 h or H2O2 (5 µg ml
-1
) for 
10 min. Each point was analyzed in triplicate and the results are shown as mean ± SD. 
All assays are representative for at least 3 independent experiments. *p<0.05; **p<0.01 























































Figure 14. Some senescence markers involved in oxidative stress are 
overexpressed in long-period BMDM cultures.  (A to C) The levels of Catalase, SOD1 
and SOD2 were measured by qRT-PCR in starved BMDM treated with recombinant M-
CSF (10 ng ml
-1
) and GM-CSF (5 ng ml
-1
)  for the indicated times. Data were expressed 
as relative mRNA levels, arbitrary units (AU), normalized to the Hprt1 expression level in 
each sample. (D) The determination of SOD enzymatic activity was performed by a 
specific colorimetric method. 10
6
 macrophages well 
-1
 were treated with M-CSF (30%), 
GM-CSF (1%) or LPS (10 ng ml
-1
) for 24 h. Supernatants were collected and analyzed. 
The enzymatic activity was expressed as percentage of activity. Each point was 




























































































































representative for at least 3 independent experiments. *p<0.05; **p<0.01 correspond to 
the statistical significance between indicated pair comparisons.   
Taken together, these results indicate that long-lasting macrophage cultures present a 
senescent phenotype but not quiescent or terminal differentiated, since most of these 
characteristics are absent in quiescent cells (Sharpless, 2004). 
 
 
DNA damage recovery is not affected in long-term cultures of 
BMDM 
The accumulation of DNA damage can induce the altered gene expression produced in 
long-lasting macrophage cultures that modifies macrophage functional activities (Di 
Micco et al., 2006). Our results indicated that 14 days BMDM presented high levels of 
DNA damage (as it was shown in Figure 13).This damage can be generated by ROS 
production and/or by a decrease in damage repair capacities. In this sense, we 
designed an experiment to determine the repair capacity after oxidative stress 
induction (Figure 15A). For this purpose, we used a stimulus that can induce oxidative 
stress and, therefore, DNA damage upon growing conditions: H2O2 treatment. After 
stimulation with H2O2 for just 1 h, complete medium with M-CSF or GM-CSF was 
reestablished to promote cell recovery. After 24 h of recovery, γ-H2AX levels were 
measured to detect DNA damage.  
In the case of M-CSF-dependent DNA repair, H2O2 treatment in 14 days BMDM caused 
an increase in the levels of γ-H2AX, as it has been reported in macrophages from old 
mice (Sebastián et al., 2009). This high levels could be reduced after 24 h of recovery 
(Figure 15B), indicating that the capacity of DNA repair after oxidative stress induction 
was not impaired in these cells. Similarly, damaged 14 days BMDM showed reduced 
levels of γ-H2AX after GM-CSF-dependent recovery, indicating that DNA repair 






Figure 15. The DNA repair capacity of senescent cells is reduced after the 
induction of oxidative stress in M-CSF-dependent recovery conditions.  (A) 
Schematic representation of BMDM stimulation to assay macrophage DNA repair 
capacity.  (B and C) M-CSF (30%)- and GM-CSF (1%)-stimulated macrophages (24 h) 
were treated with H2O2 (5 µg ml
-1
) for 1 h; the cells were washed and led to recover 
(Rec.) for 24 h. DNA damage was determined by γ-H2AX immunoblotting.  H1 image 
was used as loading control for western blots. All assays are representative for at least 3 
independent experiments.   
 
It has been previously described that treatment of BMDM with Actinomycin D (Act.D), 
Etoposide (Eto.) and H2O2 induces apoptosis (Kozmar et al., 2010; Jog et al., 2013). 
These pro-apoptotic stimuli induced elevated number of annexin-V/PI positive cells in 
young macrophages (Figure 16A and B). However, although DNA damage was 
increased in long-lasting BMDM cultures, it was not translated to a high percentage of 
apoptotic cells, quite the contrary, 14 days BMDM reduced sensitively the number of 
apoptotic cells after treatment with apoptotic stimuli (Figure 16B), being this apoptosis 
resistance a senescent characteristic extensively studied (Hampel et al., 2005).  
In addition, we explored whether the altered gene expression associated with 
senescent cells was involved in this protection to die. Thus, we evaluated the mRNA 
expression of Bcl-2, a well-known anti-apoptotic gene (Lin et al., 2001). 14 days BMDM 
showed high levels of Bcl-2 mRNA after stimulation with M-CSF and GM-CSF (Figure 
16C), suggesting that Bcl-2 high expression presented by long-lasting BMDM cultures 
































Figure 16. Long-period BMDM cultures are resistant to apoptosis.  (A and B) 
Apoptosis of macrophages cultures from normal and long-term cultures was measured 
quantifying the annexinV/PI positive cells by flow cytometry. Macrophages were treated 
with actinomycinD (ActD, 5 µg ml
-1
) for 12 h, M-CSF (10 ng ml
-1
), GM-CSF (5 ng ml
-1
) for 
24 h, Etoposide (1 µg ml
-1
 , Eto.) for 1 h and H2O2 (5 µg ml
-1
) for 10 min. (C and D)The 
levels of Bcl-2 was measured by qRT-PCR in starved BMDM  treated with recombinant 
M-CSF (10 ng ml
-1
) and GM-CSF (5 ng ml
-1
) for the indicated times. Data were 
expressed as relative mRNA levels, arbitrary units (AU), normalized to the Hprt1 
expression level in each sample. Each point was analyzed in triplicate and the results 
are shown as mean ± SD. All assays are representative for at least 3 independent 
experiments. *p<0.05; **p<0.01 correspond to the statistical significance between 
indicated pair comparisons.   
 
 
Molecular mechanism involved in cell cycle arrest observed in 
long-period cultures of BMDM 
Cellular senescence is characterized by cessation of cell growth which could be 
produced after continuous duplication/reproduction of a cell (Campisi et al., 2007). 
Moreover, with the possible exception of embryonic stem cells (Miura et al., 2004), 




























































































when appropriately stimulated (Shay and Roninson, 2004; Campisi and d’Adda di 
Fagagna, 2007). 
As permanent cell cycle arrest is the essential feature which describes senescent cells 
(Kuilman et al., 2008), we decided to study the molecular mechanism involved in the 
reduced proliferative capacity observed in 14 days BMDM. 
As it was demonstrated before (Figure 9B), macrophage proliferation in response to M-
CSF and GM-CSF was impaired in 14 days BMDM, measured biochemically and by 
cellular counting (Figure 17A to C).  
 
 
Figure 17. Proliferation is reduced in long-period BMDM cultures. Starved BMDM 
from normal and long-lasting cultures of macrophages were stimulated with different 
percentages of M-CSF (%) and GM-CSF (%) conditioned medium for 24 h. (A) 
Proliferation induced by these growth factors was determined by 
3
H-thymidine 
incorporation. Radioactivity was expressed in cpm (counts per minute). (B) Cell number 
was analyzed by cellular counting using Neubauer chamber. Macrophage concentration 
was expressed as number of cells µl
-1
. Each point was analyzed in triplicate and the 
results are shown as mean ± SD. All assays are representative for at least 3 
independent experiments.  **p<0.01 corresponds to the statistical significance between 















































































































This was also supported by a proliferation assay based on BrdU incorporation. As we 
expected, after 24 h of M-CSF and GM-CSF treatments, starved 14 days BMDM 
presented low levels of fluorescence intensity associated with BrdU cellular 
incorporation (Figure 18A and B). 
 
 
Figure 18. Long-term cultures of BMDM present a decreased BrdU incorporation in 
response to M-CSF and GM-CSF. (A and B) Starved BMDM were stimulated with 
recombinant M-CSF (10 ng ml
-1
) or GM-CSF (5 ng ml
-1
) for 24 h. Proliferation induced by 
these growth factors was determined by BrdU incorporation. Proliferation was 
represented by cell cycle graph and expressed as fluorescence intensity. All assays are 
representative for at least 3 independent experiments.   
 
Furthermore, this reduced proliferative capacity was also assayed with specific flow 
cytometry program (Multicycle Program) through the analysis of DNA content with PI. 
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to recombinant M-CSF and GM-CSF treatments, presented high number of 
macrophages at G1 phase and very low amount of cells at G2/M phase of the cell cycle 
comparing with normal BMDM (Figure 19A and B), indicating that 14 days BMDM 




Figure 19. Long-term cultures of BMDM seem to stop cell cycle at G1 phase. (A and 
B) Starved BMDM from normal and long-term cultures were stimulated with recombinant 
M-CSF (10 ng ml
-1
) or GM-CSF (5 ng ml
-1
) for 24 h. (A) Cell cycle assay was performed 
with PI and analyzed by flow cytometry.  (B) Representative table of quantitative 
measurement of the above cell cycle analysis. Each point was analyzed in triplicate and 
the results are shown as mean ± SD. All assays are representative for at least 3 
independent experiments.  *p<0.05 corresponds to the statistical significance between 
indicated pair comparisons. 
 
 
































The molecular machinery involved in the cell cycle mechanism is dependent on the 
activation of a cyclin-dependent kinases (CDKs) protein family (Bringold and Serrano, 
2000).  When quiescent cells are induced to proliferate, CDK4 and CDK6 are firstly 
activated by association with cyclin D. Activation of CDK4-6/cyclin D kinase complex 
leads to subsequent activation of the CDK2/cyclin E and CDK2/cyclin A complexes, 
which in turns mediate DNA replication and cell cycle progression (Bringold and 
Serrano, 2000).  
Moreover, there is a group of proteins known as Cyclin-dependent kinase inhibitors 
(CDKi), which reversely regulates cell cycle progression, mainly p16, p19, p21 and 
p27. p16 and p19 specifically interact and block the CDK4 and CDK6 kinases, 
inhibiting cell cycle initiation, whereas p21 and p27 inhibit CDK2/cyclin E and A kinases 
(Canepa et al., 2007).  
It has been demonstrated that senescence suppresses the molecular machinery of cell 
cycle progression inducing the up-regulation of specific cell cycle inhibitors, such as 
CDKi (mainly p16, p19 or p21) which leads to Rb hyperphosphorylation and cell cycle 
arrest (Itahana et al., 2004). However, senescence also promotes the reduction of cell 
cycle positive regulators expression, such as cyclins (mainly cyclin D and cyclin E) and 
CDKs, such as CDK2 and CDK4 (Taylor and Stark, 2001).  
In this sense, in order to investigate the cell cycle blockage presented in 14 days 
BMDM, we evaluated the mRNA expression of important senescence-related 
mediators for the cell cycle progression. Normal BMDM showed high levels of cyclin D1 
(cycD1) and cyclin E (cycE) after M-CSF treatment. However, consistently with the 
published data, 14 days BMDM displayed reduced levels in the same conditions, being 
more significant the decrease of cyclin E mRNA levels than cyclin D1 (Figure 20A). 
Similarly, GM-CSF-dependent cell cycle progression induced the expression of cyclin 
D1 and E in normal BMDM, but mRNA levels of both cyclins were reduced in 14 days 
BMDM (Figure 20B).  
Furthermore, the mRNA expression of other cell cycle positive regulators, Cdk2 and 
Cdk4, were also increased after M-CSF and GM-CSF stimulation in normal BMDM 
(Figure 21A and B). Nevertheless, the expression levels of these two kinases were 






Figure 20. Cell cycle positive regulators are down-regulated in long-lasting 
cultures of BMDM.  (A and B) CyclineD1 (cycD1) and CyclineE (cycE) levels were 
measured qRT-PCR in starved BMDM  treated with recombinant M-CSF (10 ng ml
-1
) and 
GM-CSF (5 ng ml
-1
)  for the indicated times. Data were expressed as relative mRNA 
levels, arbitrary units (AU), normalized to the Hprt1 expression level in each sample. 
Each point was analyzed in triplicate and the results are shown as mean ± SD. All 
assays are representative for at least 3 independent experiments. *p<0.05; **p<0.01 













































































Figure 21. Cell cycle positive regulators are down-regulated in long-lasting 
cultures of BMDM.  (A and B) The levels of Cycline-dependent kinase2 (Cdk2) and 
Cycline-dependent kinase4 (Cdk4) were measured by qRT-PCR in starved BMDM 
treated with recombinant M-CSF (10 ng ml
-1
) and GM-CSF (5 ng ml
-1
) for the indicated 
times. Data were expressed as relative mRNA levels, arbitrary units (AU), normalized to 
the Hprt1 expression level in each sample. Each point was analyzed in triplicate and the 
results are shown as mean ± SD. All assays are representative for at least 3 
independent experiments. *p<0.05; **p<0.01 correspond to the statistical significance 
between indicated pair comparisons.   
 
We also explored the potential role of cell cycle inhibitors in macrophage senescence-
dependent proliferation blockage. In this sense, we stimulated normal and long-lasting 
cultures of BMDM with M-CSF or GM-CSF growth factors. Whereas we could not 
detect differences in p21 mRNA levels between normal and 14 days BMDM, the 
reduced proliferative capacity presented in long-period cultures of BMDM seems to be 
affected by extraordinary levels of p16 and high levels of p27 mRNA expression in 14 
days BMDM (Figure 22A and B). 
 
Taken together, these data suggest that 14 days BMDM are unable to progress in the 






































































positive regulators of cell cycle, such as cyclin E and Cdk2, are down-regulated, 
obtaining a reduced amount of cyclin-kinase complexes and, therefore, damaging the 
advancement of cell cycle. Additionally, this is also accompanied and sustained by the 
overexpression of some CDKi, such as p27 and p16. 
 
 
Figure 22. p27 and p16, mainly,  are involved in the cell cycle blockage of long-
lasting cultures of BMDM.  (A and B) The levels of p21, p27 and p16 were measured 
by real-time PCR in starved BMDM treated with recombinant M-CSF (10 ng ml
-1
) and 
GM-CSF (5 ng ml
-1
)  for the indicated times. Data were expressed as relative mRNA 
levels, arbitrary units (AU), normalized to the Hprt1 expression level in each sample. 
Each point was analyzed in triplicate and the results are shown as mean ± SD. All 
assays are representative for at least 3 independent experiments. *p<0.05; **p<0.01 
correspond to the statistical significance between indicated pair comparisons.   
 
Next, to further evaluate the involvement of senescence-related oncogenes (OIS) in the 
impaired cell cycle regulation observed in long-lasting cultures of BMDM, we measured 
the mRNA levels of some oncogenes, such as c-Myc, Raf and E2F1, that are also 
important senescence markers (Grandori et al., 2003; Courtois-Cox et al., 2006; 









































































































c-Myc is an oncogenic transcription factor that is frequently upregulated in human 
malignancies (Nesbit et al., 1999), such as melanoma (Ross and Wilson, 1998; 
Greulich et al., 2000; Kraehn et al., 2001). In normal human cells, overexpression of c-
Myc promotes the acquisition of a transformed phenotype in cooperation with other 
cellular oncogenes (Boehm et al., 2005). Moreover, in mice c-Myc upregulation has 
been shown to induce tumorigenesis in numerous transgenic models (Lutz et al., 
2002). However, it is also demonstrated that the overexpression of c-Myc is correlated 
with the progression and maintenance of cellular senescence (Zhuang et al., 2008). 
In the case of Raf oncogene its overexpression can promote a robust induction of 
senescence produced by two different senescence pathways that work in parallel: the 
accumulation of CDKi, such as p16, p21 and p27 and the activation of DNA-damage 
mechanisms with the subsequent phosphorylation of Ɣ-H2AX (Jeanblanc et al., 2012). 
Similarly, the transcription factor E2F1 has been proved to be a cellular senescence 
modulator whose overexpression suppresses the progression of cancer and induce 
cellular senescence, providing the possibility to use E2F1 as a therapeutic target in the 
treatment of cancer (Park et al., 2006). 
As we expected, 14 days BMDM showed increased mRNA expression of c-Myc after 
M-CSF and GM-CSF treatment comparing with the amounts produced by normal 
BMDM (Figure 23A and B). Similarly, the stimulation of 14 days BMDM with both 
growth factors induced high levels of Raf and E2F1 mRNA expression (Figure 23A and 
B), indicating that cellular senescence induced in long-period cultures of BMDM is also 







Figure 23. Senescence markers involved in cell cycle regulation are 
overexpressed in long-lasting cultures of BMDM.  (A and B) The levels of c-Myc, Raf 
and E2F1 were measured by qRT-PCR in starved BMDM treated with recombinant M-
CSF (10 ng ml
-1
) and GM-CSF (5 ng ml
-1
)  for the indicated times. Data were expressed 
as relative mRNA levels, arbitrary units (AU), normalized to the Hprt1 expression level in 
each sample. Each point was analyzed in triplicate and the results are shown as mean ± 
SD. All assays are representative for at least 3 independent experiments. *p<0.05; 
**p<0.01 correspond to the statistical significance between indicated pair comparisons.   
 
Furthermore, in a previous work from our laboratory, it was demonstrated that GM-CSF 
growing pathway was altered in macrophages from old mice due to Janus kinase 2 
(Jak2)/STAT5 impaired signaling pathway (Sebastián et al., 2009). STAT5 is involved 
in the proliferation of many cell types. Once phosphorylated, STAT5 dimerizes and 
translocates to the nucleus where it binds to DNA-specific sites and activates the 
transcription of target genes (Hou et al., 1995; de Groot et al., 1998). In this sense, the 
cell cycle arrest shown by 14 days BMDM was correlated with a decrease in the 








































































































Figure 24. The phosphorylation of STAT5 is reduced in long-period BMDM 
cultures.  Starved BMDM were stimulated with recombinant GM-CSF (5 ng ml
-1
) for the 
times indicated. (A) STAT5 phosphorylation was determined by p-STAT5 
immunoblotting. (B) Representative graph of the quantitative measurement of the 
immunoblotting above.  STAT5 image was used as loading control for western blots. All 
assays are representative for at least 3 independent experiments.   
 
Next, in order to investigate the signaling pathway involved in the blockage of cell cycle 
progression presented by long-lasting cultures of BMDM, we also evaluate the 
activation of crucial MAPKs implicated in macrophage proliferation, such as 
extracellular signal-related kinase (ERK1/2), c-Jun N-terminal kinase (JNK) and p38 
MAPK (Valledor et al., 2008). MAPKs are evolutionarily conserved serine/threonine 
kinases involved in the transduction of externally derived signals that regulate cell 
growth, differentiation and apoptosis (Seger et al., 1995).  
These kinases directly modulate downstream targets by phosphorylation, including 
additional protein kinases, components of the cytoskeleton and transcriptional 
regulators which in turn promote immediate early gene expression (Valledor et al., 
2008).  
In a previous study, we observed that activation of the ERK cascade is specifically 
required for macrophages to proliferate in response to M-CSF and GM-CSF (Valledor 
p-STAT5
STAT5
0 15 30 0 15 30 rGM-CSF


































et al., 1999). The proliferation of normal BMDM induced by GM-CSF produced the 
phosphorylation at 15 min of p38 MAPK, JNK and ERK1/2 (Figure 25A and B). 
However, GM-CSF induced an overactivation and more sustained ERK and p38 MAPK 
phosphorylation in 14 days BMDM, whereas JNK activity was not affected, as 
determined by the prolonged phosphorylation kinetics (up to 2 h) presented by ERK 
and p38 MAPK activity in response to GM-CSF (Figure 25B).  
Previous studies of our research group have demonstrated that alteration in the 
kinetics of ERK1/2 phosphorylation have profound effects on macrophage proliferation 
and activation (Valledor et al., 2008), but no previous data on the role of p38 MAPK 
was described in those studies. 
 
 
Figure 25. GM-CSF treatment induces prolongation of p38 MAPK and ERK 
phosphorylation in long-period BMDM cultures.  Starved BMDM were stimulated with 
recombinant GM-CSF (5 ng ml
-1
) for the times indicated. (A and B) ERK, JNK and p38 
phosphorylation was determined by p-ERK, p-JNK and p-p38 immunoblotting. β-actin 
image was used as loading control for western blots. All assays are representative for at 
least 3 independent experiments.   
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Interestingly, this also occurred when these cells were stimulated with M-CSF (Figure 
26A and B) but this behavior is distinct to macrophages from old mice since they did 
not alter MAPK activity (Sebastián et al., 2009). Nevertheless, some data implicate 
MAPK overactivation with senescence (Sebastián, Lloberas and Celada, 2009). These 
observations suggest that STAT5, ERK and p38 activity play an important role in the 




Figure 26. M-CSF treatment induces prolongation of p38 MAPK phosphorylation in 
long-period BMDM cultures.  Starved BMDM were stimulated with recombinant M-CSF 
(10 ng ml
-1
) for the times indicated. (A and B) ERK, JNK and p38 phosphorylation was 
determined by p-ERK, p-JNK and p-p38 immunoblotting. β-actin image was used as 
loading control for western blots. All assays are representative for at least 3 independent 




p16 and telomeres shortening are involved in the cellular 
senescence molecular mechanisms of long-period BMDM 
cultures 
At molecular level, replicative senescence is controlled by two different pathways which 
comprise the tumor suppressor proteins pRb and p53 and their corresponding effectors 
p16 and p21 (Dimri and Campisi, 1995; Campisi, 2001). Consistently, inactivation of 
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In this regard, we evaluated the possibility that p53 pathway was involved in the 
senescence mechanism induced in long-period cultures of BMDM. Normal and 14 days 
BMDM were stimulated with recombinant M-CSF (growing conditions) and with 
etoposide (Eto.) and H2O2 treatments, as DNA-damage inducers (p53 positive 
activators) and p53 phosphorylation was measured by western blotting. In both, normal 
and 14 days BMDM, p53 was not activated by M-CSF treatment, whereas etoposide 
and H2O2 stimulation induced the phosphorylation of p53 at similar levels (Figure 27A). 
Additionally, as it was demonstrated before (Figure 22), p21 mRNA expression was 
similar in both types of macrophage cultures, indicating that p53-p21 senescence 
pathway is not involved in the molecular mechanism induced in long-term cultures of 
BMDM (Figure 27B).  
In contrast, p16 mRNA levels were extraordinary high in 14 days BMDM comparing 
with normal macrophages after stimulation with recombinant M-CSF and GM-CSF 
growing factors (Figure 27C), suggesting that pRb-p16 pathway seems to be the 
molecular mechanism implicated in the senescence process produced in 14 days 
BMDM. 
The relative contribution of pRb and p53 cascades to senescence depends on the cell 
type but both mechanisms ultimately undergo telomeric crisis, resulting in 
chromosomal instability (Shay and Wright, 2005). Therefore, the dependence of 
replicative senescence on telomere shortening is evident from its bypass by the ectopic 
expression of the catalytic subunit of the telomerase holoenzyme (hTERT), which 
elongates telomeres, thereby abrogating the effect of the end replication problem 
(Bodnar et al. 1998; Vaziri and Benchimol 1998). In contrast to those cells that need to 
divide regularly (stem cells and immune cells, among others), many somatic cells are 
not able to express telomerase, thus, they are incapable to maintain telomeres at a 
sufficient length to prevent DDR (Masutomi et al., 2003). In this sense, we wanted to 
determine the importance of telomere attrition observed for the macrophage 







Figure 27. The mechanism involved in the senescence process of long-lasting 
BMDM cultures seems to be driven by p16.  (A) Starved BMDM were stimulated with 
recombinant M-CSF (10 ng ml
-1
), Etoposide (1 µg ml
-1
 , Eto.) and H2O2 (5 µg ml
-1
) for 30 
min. p53 phosphorylation was measured by p-p53 immunoblotting.  β-actin image was 
used as loading control for western blots. (B and C) The levels of p21 and p16 were 
measured by qRT-PCR in starved BMDM treated with recombinant M-CSF (10 ng ml
-1
) 
and GM-CSF (5 ng ml
-1
)  for the indicated times. Data were expressed as relative mRNA 
levels, arbitrary units (AU), normalized to the Hprt1 expression level in each sample. 
Each point was analyzed in triplicate and the results are shown as mean ± SD. All 
assays are representative for at least 3 independent experiments. **p<0.01 correspond 
to the statistical significance between indicated pair comparisons.   
 
For this purpose, we used a weak telomerase activator, termed TA-65 that promotes 
the elongation of telomere caps on chromosomes (Harley et al., 2011). During long-
















































































period cultures of BMDM generation, TA-65 was added into the complete medium 
every 48 h up to get 14 days BMDM, and adding DMSO in normal and control 14 days 
macrophages to adjust the assay. To determine the optimal concentration of TA-65 
pre-treatment that induces the elongation of telomeres, first we evaluated the telomere 
length of normal and 14 days BMDM in the presence or absence of different 
concentrations of TA-65 through qRT-PCR, being 10 µM the concentration of TA-65 
that enhances the highest level of T/S ratio in 14 days BMDM (Figure 28A). Moreover, 
the increase in the telomere length observed in 14 days BMDM induced by TA-65 
(Figure 28B) was correlated with an incomplete increase in the proliferative capacity of 
14 days BMDM in response to M-CSF and GM-CSF (Figure 28C), suggesting that 
telomeres attrition plays a partial role in the impaired proliferative capacity of long-
period cultures of BMDM. 
 
Figure 28. Telomerase activation partially rescues the impaired proliferative 
capacity of long-period BMDM cultures.  (A and B) Telomere length was measured by 
qRT-PCR in normal and 14 days macrophages with or without TA-65 at the 
concentrations indicated (see Materials and Methods section). The ratio of relative 
telomere to single copy gene (36B4) amplification (T/S) was shown by two independent 
experiments. (C) Starved BMDM were stimulated with M-CSF (30 %) and GM-CSF (1 %) 
conditioned medium for 24 h with or without TA-65 (10 µM). Proliferation induced was 
determined by 
3
H-thymidine incorporation. Radioactivity was expressed in cpm (counts 
per minute). Each point was analyzed in triplicate and the results are shown as mean ± 
SD. All assays are representative for at least 3 independent experiments.  *p<0.05; 





























































































Determination of functional 









Classical and alternative activation phenotypes are impaired in 
long-term BMDM cultures 
The idea of macrophage activation appeared as a result of the observation that 
macrophages treated with bacterial constituents, such as LPS or flagellin, and IFN-γ 
developed an enhanced capacity to destroy a wide range of ingested pathogens. 
Classically activated macrophages (M1 macrophages) have an increased ability to 
present antigen since they increase the expression of MHC II and CD80/CD86 (Herrero 
et al., 2002). In addition, M1 macrophages mediate diverse inflammatory effects 
secreting a variety of cytokines and destroying intracellular pathogens through 
increasing the production of NO and other effector molecules (Xu and Gordon, 2003).  
In contrast, alternative activated macrophages (M2 macrophages), produced by IL-4 or 
IL-13 treatments, do not display an increased oxidative burst and are inefficient in 
killing intracellular pathogens. These macrophages are important in clearance of 
parasitic and extracellular pathogens and promote cell growth and tissue remodeling 
through the induction of arginase (Gratchev et al., 2001). Moreover, unlike classical 
macrophage phenotype, M2 macrophages increase the expression of mannose 
receptor 1 (mrc1) and macrophage galactose-type lectin 1 (mgl1) and specific 
transcription factors such as resistin-like molecule alpha (Fizz1) (Stein et al., 1992; 
Iniesta et al., 2001; Gratchev et al., 2001; Gordon, 2003). 
Due to the importance of macrophage activities in the steady state or during an 
inflammatory process, we next decided to study important macrophage functions based 
on phenotypic characteristics. Regarding to the macrophage classical activation, we 
analyzed MHCII mRNA and protein expression induced by IFN-γ in 14 days BMDM. As 
it was reported in macrophages from old mice (Herrero et al., 2002), we observed a 
reduction of I-Ab expression after 48 h of IFN-γ treatment (Figure 29A). Consistent with 
the decreased mRNA levels, the protein surface expression of I-Ab was also reduced 
in 14 days BMDM samples (Figure 29B and C), indicating that antigen presentation 






Figure 29. Antigen presentation capacity is impaired in long-period BMDM 
cultures.  (A) The levels of I-Ab were measured by qRT-PCR in starved BMDM treated 
with recombinant IFN-γ (20 µg ml
-1
) for the times indicated. Data were expressed as 
relative mRNA levels, arbitrary units (AU), normalized to the Hprt1 expression level in 
each sample. (B and C) MHCII surface expression was measured by flow cytometry. 
BMDM were stimulated with recombinant IFN-γ (20 µg ml
-1
) for 48 h and stained with I-
Aβ-FITC and Cd11b-PE antibodies.  Data were expressed as percentage of positive 
cells (B) or fluorescence intensity (C). Each point was analyzed in triplicate and the 
results are shown as mean ± SD. All assays are representative for at least 3 
independent experiments. **p<0.01 correspond to the statistical significance between 
indicated pair comparisons.   
 
In addition, we proposed determine other essential M1 functions such as the ability to 
destroy intracellular pathogens through the oxidative burst. In this sense, the 
stimulation with LPS induced the mRNA and protein expression of NOS2 at high levels 
in normal BMDM (Figure 30A and B). However, 14 days BMDM presented a significant 
decreased of NOS2 expression at mRNA and protein levels in response to LPS (Figure 















































induced by LPS or by LPS plus IFN-γ in 14 days BMDM, suggesting that the 
microbicidal activity was highly reduced in these macrophages (Figure 30C).  
 
 
Figure 30. Microbicidal activity is reduced in long-period BMDM cultures.  (A) The 
levels of nos2 was measured by qRT-PCR in starved BMDM treated with LPS (10 ng ml
-
1
) for  the times indicated. Data were expressed as relative mRNA levels, arbitrary units 
(AU), normalized to the Hprt1 expression level in each sample. (B) BMDM were 
stimulated with LPS (10 ng ml
-1
) for 24 h. NOS2 protein expression was measured by 
western blot.  β-actin image was used as loading control for western blots. (C) NO 
production was analyzed by absorbance. BMDM were stimulated with LPS (10 ng ml
-1
) 
or with LPS (10 ng ml
-1
) plus recombinant IFN-γ (20 µg ml
-1
) for 24 h.  Each point was 
analyzed in triplicate and the results are shown as mean ± SD. All assays are 
representative for at least 3 independent experiments. **p<0.01 correspond to the 
statistical significance between indicated pair comparisons.   
 
Next, we also evaluated the expression and secretion of pro-inflammatory cytokines in 
response to LPS. Thus, normal and 14 days BMDM were treated with LPS at different 
time points and mRNA and protein levels of IL-1β and TNF-α were measured. IL-1β 
mRNA and protein expression was increased in 14 days BMDM in response to LPS 
(Figure 31A and B). Consistently, the treatment with ATP, required to induce the 
release of IL-1β in LPS-primed macrophages through inflammasome activation 
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in 14 days BMDM (Figure 31C). Similarly, the mRNA levels (Figure 31D) and the 
secretion of TNF-α (Figure 31E) were also augmented in 14 days BMDM. 
 
 
Figure 31. Pro-inflammatory cytokines secretion is increased in long-period BMDM 
cultures.  (A and D) The levels of il-1b and tnf-α were measured by qRT-PCR in starved 
BMDM treated with LPS (10 ng ml
-1
) for the times indicated. Data were expressed as 
relative mRNA levels, arbitrary units (AU), normalized to the Hprt1 expression level in 
each sample. (B) BMDM were stimulated with LPS (10 ng ml
-1
) for 24 h. IL-1β protein 
expression was measured by western blot.  β-actin image was used as loading control 
for western blots. (C and E) Cytokine production was analyzed by ELISA. BMDM were 
stimulated with LPS (10 ng ml
-1
) or with LPS (10 ng ml
-1
) plus ATP (1 mM) for 24 h.  
Each point was analyzed in triplicate and the results are shown as mean ± SD. All 
assays are representative for at least 3 independent experiments.  *p<0.05; **p<0.01 
correspond to the statistical significance between indicated pair comparisons.   
 
Since it was clear that pro-inflammatory cytokines were overexpressed in long-period 
cultures of BMDM, we also decided to determine the levels of IL-10, an anti-
inflammatory cytokine crucial for limiting the innate immune response to pathogens 
(Saraiva and O’Garra, 2010). IL-10 is transcriptionally induced by LPS stimulation via 
STAT-3 activation (Carl et al., 2004) and has an inhibitory effect on the production of 
several inflammatory cytokines including TNF-α (Armstrong et al., 1996). Il-10 mRNA 
and secretion levels were higher in 14 days BMDM comparing with normal BMDM in 
response to LPS (Figure 32A and B). Additionally, LPS treatment induced a peak of 






















































































expected, 14 days BMDM presented an increase STAT-3 activity whose 
phosphorylation was also sustained at 30 min (Figure 32C).   
Taken together, these results indicate that macrophage M1 activation by IFN-γ and 
LPS stimulation were deficient in long-period BMDM cultures. 
 
 
Figure 32. IL-10 secretion is increased in long-period BMDM cultures.  (A) The 
levels of il-10 were measured by qRT-PCR in starved BMDM treated with LPS (10 ng ml
-
1
) for the times indicated. Data were expressed as relative mRNA levels, arbitrary units 
(AU), normalized to the Hprt1 expression level in each sample. (B) BMDM were 
stimulated with LPS (10 ng ml
-1
) for 24 h and IL-10 production was analyzed by ELISA. 
(C)  BMDM were stimulated with LPS (10 ng ml
-1
) for the times indicated and STAT-3 
phosphorylation was measured by western blot.  β-actin image was used as loading 
control for western blots. Each point was analyzed in triplicate and the results are shown 
as mean ± SD. All assays are representative for at least 3 independent experiments. 
**p<0.01 correspond to the statistical significance between indicated pair comparisons.   
 
An innovative hypothesis of cellular senescence contribution to the age-related 
changes of the immune system explains that immunosenescence and inflammaging 
can also be derived from a dysfunction of TLRs expression and TLRs signaling since 
TLRs activation results in pro-inflammatory mediators induction (Olivieri et al., 2013).  
The age-related expression of the TLRs has been extensively studied in cells of the 
innate immunity, mainly neutrophils and macrophages obtaining complex results. In 
this sense, we decided to evaluate the surface (TLR-2, -4 and -5) or intracellular (TLR-



































0   15     30  0 15   30 LPS












Whereas we did not observe any difference in TLRs expression at basal levels 
between normal and 14 days BMDM, TLRs levels after LPS treatment showed 
alterations (Figure 33). In the case of TLR-2 expression, 14 days BMDM presented 
lower percentage of positive cells than normal macrophages (Figure 33A). In contrast, 
TLR-4, -5 and -9 were overexpressed in these cells after LPS treatment (Figure 33B to 
D), which could explain, in part, the increase in pro-inflammatory cytokines expression 
shown in long-period cultures of BMDM. 
 
 
Figure 33. The expression of TLR-4, -5 and -9 are increased in long-period BMDM 
cultures.  (A to D) TLRs surface expression was measured by flow cytometry. BMDM 
were stimulated with LPS (10 ng ml
-1
) for 24 h and stained with TLR-2, 4, 5, 9-FITC 
antibodies.  Data were expressed as percentage of positive cells. Each point was 
analyzed in triplicate and the results are shown as mean ± SD. All assays are 
representative for at least 3 independent experiments. *p<0.05; **p<0.01 correspond to 
the statistical significance between indicated pair comparisons.   
 
Regarding to the alternatively activated macrophage functions, first we evaluated the 
M2 most important marker: the expression and activity of arginase-1 (Gordon, 2003). 
Normal and 14 days BMDM were stimulated with IL-4 for 8 or 24h in order to induce 
the M2 macrophage switching. As we expected, normal BMDM treated with IL-4 











































































expression was significantly reduced in 14 days BMDM (Figure 34A). Additionally, we 
also measured the enzyme activity through a colorimetric method based on the 
reaction produced between arginase and the aminoacid L-arginine. Arginase activity 
was declined in 14 days BMDM after IL-4 treatment (Figure 34B), indicating that tissue 




Figure 34. Arginase activity is reduced in long-period BMDM cultures.  (A) The 
levels of argI was measured by qRT-PCR in starved BMDM treated with IL-4 (10 ng ml
-1
) 
for the times indicated. Data were expressed as relative mRNA levels, arbitrary units 
(AU), normalized to the Hprt1 expression level in each sample. (B) BMDM were 
stimulated with IL-4 (10 ng ml
-1
) for 24 h and arginase activity was measured by 
absorbance. Data were expressed as enzymatic activity (mU).  Each point was analyzed 
in triplicate and the results are shown as mean ± SD. All assays are representative for at 
least 3 independent experiments. *p<0.05; **p<0.01 correspond to the statistical 
significance between indicated pair comparisons.   
 
Moreover, we analyzed some transcription factor or genes involved in M2 phenotype 
after IL-4 stimulation. In the case of mgl1 and fizz1 were also reduced in 14 days 
BMDM (Figure 35A and B) confirming few data concerning how aging may affect the 
alternative activation of macrophages (Smith et al., 2001). However, M2 genes such as 
mrc1 and tgfβ were increased and not affected, respectively (Figure 35C and D) 
indicating that some, but not all, M2 genes contribute to the altered long-lasting 
















































Figure 35. Some genes involved in the alternative activation are differently 
expressed in long-period BMDM cultures.  (A to D) The levels of mgl1, fizz1, tgfβ and 
mrc1 were measured by qRT-PCR in starved BMDM treated with IL-4 (10 ng ml
-1
) for the 
times indicated. Data were expressed as relative mRNA levels, arbitrary units (AU), 
normalized to the Hprt1 expression level in each sample. Each point was analyzed in 
triplicate and the results are shown as mean ± SD. All assays are representative for at 
least 3 independent experiments. *p<0.05; **p<0.01 correspond to the statistical 
significance between indicated pair comparisons.   
 
Finally, to complete the functionality study of long-term cultures of BMDM, we 
evaluated the phagocytic activity, one of the most important actions that macrophages 
carry out.  
Phagocytosis by macrophages is critical for uptake and degradation of infectious 
agents and senescent or apoptotic cells, and it participates in development, tissue 
remodeling, immune response and inflammation (Aderem and Underhill, 1999). 
Phagocytosis is extremely complex and no single model can fully account for the 
diverse structures and outcomes associated with particle internalization. This 
complexity is in part due to the diversity of receptors capable to stimulate phagocytosis 
and also due to the capacity of a variety of microbes to influence their fate as they are 















































































In this sense, we measured the ability of senescent macrophages derived from our 
cellular model to engulf apoptotic cells. For this purpose, we used MDA-MB-231/GFP 
(MDA-GFP) cell line, green-fluorescence epithelial cells which stably express GFP. To 
obtain apoptotic MDA-GFP cells, we treated them with actinomycin D (Figure 36A). 
Phagocytosis was analyzed by microscopy putting in contact normal BMDM with 
apoptotic MDA-GFP cells in a proportion of 1:10.  
We could observe that normal BMDM were able to engulf apoptotic epithelial cells 
since we detected green fluorescence in BMDM samples (Figure 36B). In addition, 
phagocytosis activity in senescent macrophages was quantified by flow cytometry 
method. As negative control we used a pre-treatment with cytochalasin D, a 
phagocytosis inhibitor, and low temperature (4ºC), to prevent the engulfment of 
apoptotic bodies. In normal BMDM the phagocytic activity was increased after 
apoptotic cells incubation, however, this activity was significantly suppressed in 14 
days BMDM (Figure 36C), indicating that macrophage phagocytic activity is impaired in 
long-period cultures of BMDM. 
 
Figure 36. Phagocytic capacity is impaired in long-period BMDM cultures.  (A) 
Representative image of apoptotic MDA-MB-231/GFP cells. Cells were treated with 
Actinomycin D (5 µg ml
-1
) for 6 h. (B) Representative image of MDA-MB-231/GFP cells 
phagocyted by BMDM. BMDM were treated in a proportion of 10:1 with apoptotic MDA-
MB-231/GFP cells for 1 h. Images were acquired with a fluorescent inverted microscope. 
(C) BMDM, at 4ºC or 37ºC, were treated with the presence or absence of a pre-
stimulation of cytochalasin D (Cyt.D, 2 µg ml
-1






































MDA-MB-231/GFP cells for 1 h. GFP positive cells were analyzed by flow cytometry and 
data were expressed as percentage of phagocytic cells. Each point was analyzed in 
triplicate and the results are shown as mean ± SD. All assays are representative for at 
least 3 independent experiments. **p<0.01 correspond to the statistical significance 
between indicated pair comparisons.   
 
Thus, taking into account the innate immune functionalities of macrophages studied in 
this work, we could determine that long-period BMDM cultures presented a great 
number of altered macrophage activities that could contribute to some aspects of the 
























Macrophages are white blood cells localized within tissues, arising from the 
differentiation of monocytes. These cells play a critical role in the development of the 
innate immune response since they act as sentinels carrying out different functions in 
tissues (Xu and Gordon, 2003). They are specialized to phagocyte and eliminate 
foreign particles (bacteria, viruses, parasites, macromolecules and damaged cells), 
limiting the anti- inflammatory process. Moreover, macrophages can also participate in 
the systemic immune modulation through the production of cytokines and chemokines, 
antigen presentation and the regulation of T cell activation and differentiation, linking 
the innate immunity to the adaptive (Bowdish et al., 2007). 
Although, it is well documented that innate and adaptive immunity are deteriorated 
progressively with advancing age (Hu et al., 1993; Linton et al., 1996; Linton et al., 
1997; Beverly and Grubeck-Loebenstein, 2000; Franceschi et al., 2000; Johnson and 
Cambier, 2004), the specific impact on macrophages has to be resolved. The 
inappropriate macrophage function produced by aging contribute significantly to 
decreased pathogens clearance and decreased responsiveness of the adaptive 
immune system, participating in the immunosenescence process (Plackett et al., 2004). 
We show here that our novel murine senescent macrophage model, based on long-
period cultures of BMDM, present altered macrophage functions similarly to those 
observed in macrophages obtained from old mice. Interestingly, this cellular model also 
show numerous senescent characteristics which demonstrate that cellular senescence 
induced in long-term cultures of BMDM may be a good tool to evaluate the impaired 
macrophage functions produced during the aging process, MacrophAging. 
 
Long-term cultures of BMDM are senescent macrophages 
Very few data are available regarding the cellular and molecular mechanisms involved 
in macrophage aging and senescence (Pinke et al., 2013; Pinto et al., 2014; Stranks et 
al., 2015). Most studies use BMDM from young (6 week-old) and aged mice (24 month-
old) grown and differentiated in vitro to prevent the influence of other cell types that 
may be affected by the aging process (Herrero et al., 2002; Sebastián et al., 2009). 
However, working with old mice carries many problems. For instance, researchers 
must wait 24 months to get aged mice, long time and many economic costs to initiate 
the investigation. In addition, during this waiting period may occur different 
uncontrollable complications: some mice can die by natural death or even they can get 




To resolve this, some studies from our research group used the first and third 
generation of mice lacking the gene encoding the telomerase RNA component (Terc-/-) 
(Sebastián et al., 2009). These mice show progressive telomere shortening in 
successive generations with signs of premature aging (Samper et al., 2002).  However, 
for this work we decided to design an innovative cellular model of senescence to study 
aging on macrophages. Actually, the use of replicative life span of cell cultures as a 
model for aging has been accepted because in vitro life span correlates with species 
maximum life span potential (Demetrius, 2006) and, most importantly, cultures of 
normal human and mice cells have been reported to exhibit frequently a negative 
correlation between proliferative capacity and the age of the donor from whom the 
culture was established (Cristofalo et al., 1998; Ksiazek et al., 2007). However, even in 
rodents, the relationship between donor age and proliferative potential is not 
completely clear (Bruce and Deamond, 1991; Deamond and Bruce, 1991). Although 
the loss of proliferative potential in vitro may not directly reflect changes in replicative 
capacity that occur in vivo during organismal aging, cell cultures remain a powerful tool 
for a variety of aging-related studies such as stress effects, loss of cellular functions 
and basic mechanisms of aging. 
Our senescent macrophage model was established by sequential passaging until 
BMDM growth ceased and failed to divide, similarly to other in vitro senescent cellular 
models (Effros et al., 2003; Ksiazek et al., 2007; Phipps et al., 2007), maintaining the 
specific macrophage marker Cd11b and their particular size and complexity. The 
results found show that long-period cultures of BMDM reduces their proliferative 
potential in response to two macrophage specific growth factors, M-CSF and GM-CSF. 
In this regard, we evaluated macrophage proliferation by different approaches in order 
to demonstrate the most important and indispensable senescent feature, the 
irreversible growth arrest. Radioactive thymidine incorporation and cellular counting are 
decreased in long-term cultures of BMDM. In addition, these BMDM cultures present 
less BrdU incorporation and a cell cycle blockage at G1 phase measured by cell cycle 
analysis based on PI staining. However, previous studies from our research group 
showed that although GM-CSF-dependent proliferation was significantly reduced in 
aged BMDM obtained from old mice, the proliferative capacity in response to M-CSF 
treatment was similar to young BMDM (Sebastián et al., 2009). 
Furthermore, our results demonstrate that 14 days BMDM, obtained through serial 
divisions, are positive for diverse senescent markers. As reported in this thesis, 
replicative senescence is associated with widespread and persistent changes in long-




phenotype. Such changes include high activity of SA-β-gal and morphological changes. 
It has been demonstrated that senescent cells raise SA-β-gal activity reflecting the 
increase in lysosomal mass (Lee et al., 2006). Additionally, senescent cells increase in 
size, sometimes enlarging more than twofold relative to the size of non-senescent 
counterparts (Hayflick, 1965). However, we could only detect that long-period BMDM 
cultures are more rounded and have less dendritic morphology than normal BMDM.  
Previous macrophage aging studies showed that aged BMDM were unable to maintain 
telomeres at a sufficient length to prevent DDR resulting in impaired proliferation 
(Harley et al., 1990; Wright et al., 1996; Masutomi et al., 2003; Sebastián et al., 2009). 
In fact, hematopoietic stem cells show telomere shortening during in vitro culture and in 
vivo aging (Vaziri et al., 1994; Engelhardt et al., 1997; Zimmermann et al., 2004) 
similarly to several mouse stem cell compartments, including skin, small intestine, 
cornea, testis and brain (Flores et al., 2008). This work demonstrate that long-term 
cultures of BMDM present shorter telomeres which correlates with signs of persistent 
activation of a DDR, as evidenced by γ-H2AX-positive.   
In addition to these features, we have shown that our senescent cellular model suffers 
an enhanced oxidative stress which is related with telomeres shortening (von Zglinicki 
et al., 2002; Tchirkov and Lansdorp, 2003). This higher production of intracellular ROS 
associates with the mRNA expression of senescent markers connected with oxidative 
stress (de Haan et al., 1996), such as higher catalase and SOD2 expression, while 
SOD1 seems not to be affected by the induction of senescence. However, results 
published regarding SOD homologues expression are controversial. While, some 
reports indicate that both, SOD1 and SOD2, are upregulated at mRNA level in 
senescent cells (de Haan et al., 1996), other studies confirm that SOD1 mRNA 
expression was overexpressed, and SOD2 was not affected (Kawamura and 
Sunanaga, 2013). Even so, in agreement with these previous reports, SOD activity is 
reduced in long-term cultures of BMDM, contributing to the redox imbalance. 
Therefore, the results obtained confirm that long-period cultures of BMDM display a 
senescent phenotype characterized, mainly, by irreversible exit of the cell cycle and by 
changes in macrophage shape, increased SA-β-gal activity, telomeres shortening, 
enhanced oxidative stress and persistent DNA damage. 
We have also investigated the molecular mechanism involved in the cell cycle blockage 
induced in long-term cultures of BMDM. The cell cycle arrest at G1 phase has been 
correlated with the origin of cellular senescence (Magalhaes, 2004). According to the 




such as p16 and p27 which are able to inactivate G1 proteins such as CDK4/cycD and 
CDK2/cycE complexes (Kuilman et al., 2010; Rodier and Campisi, 2011). It has been 
established that p16 expression increases with age in mice and humans (Zindy et al., 
1997; Nielsen et al., 1999; Krishnamurthy et al., 2004; Ressler et al., 2006; Liu et al., 
2009), and its activity has been functionally linked to the reduction in progenitor cell 
number that occurs in multiple tissues during aging (Janzen et al., 2006; Krishnamurthy 
et al., 2006; Molofsky et al., 2006). However, although commonly high levels of p21 are 
required for the induction of senescence-related growth arrest (Sherr and Roberts, 
1999; Chang et al., 2000; Romanov et al., 2010), other studies demonstrate that p21 
overexpression is not crucial (Medcalf et al., 1996; Brown et al., 1997). In this sense, in 
our senescent macrophage model p21 mRNA levels are not affected in response to M-
CSF and GM-CSF stimulation. Moreover, in concordance with previous studies, we 
also proved that the expression of cycD and cycE as well as Cdk2 and Cdk4 are 
reduced in these macrophages (Kuilman et al., 2010; Blagosklonny, 2011).  
Next, we decided to study the signaling involved in the cell cycle arrest induced in long-
period cultures of BMDM. M-CSF and GM-CSF induce macrophage proliferation by 
stimulating a complex array of signal transduction pathways, including MAPKs (Pixley 
and Stanley, 2004). Three different MAPKs (ERK1/2, JNK and p38) are activated in 
response to M-CSF and GM-CSF treatments (Jaworowski et al., 1999; Valledor et al., 
2000; Comalada et al., 2004; Sánchez-Tilló et al., 2007). Paradoxically it has been 
demonstrated that prolongation in ERK1/2 phosphorylation triggers cell cycle arrest 
involved in cellular senescence since correlates with high levels of p16 (Valledor et al., 
2008; Deschenes-Simard et al., 2013). Similarly, high p38 MAPK activity drives 
senescence through inhibition of telomerase activity, upregulation of p16 mRNA and by 
induction of DDR signaling in some immune cells such as T cells (Lanna et al., 2014). 
In contrast, loss of JNK activity has been related with the activation of Bcl-2/ROS/DDR 
signaling cascade that ultimately leads to premature senescence (Lee et al., 2010; 
Spallarossa et al., 2010). In this regard, we evaluated the activity of these MAPKs in 
response to M-CSF and GM-CSF by western blot.  
The prolongation of ERK and p38 MAPK phosphorylation was detected in long-period 
cultures of BMDM. However, normal and senescent macrophages present similar JNK 
activity levels. These results suggest that both, ERK and p38 MAPK, are implicated in 
the induction of growth arrest in BMDM, while JNK activity seems to be irrelevant. 
Nevertheless, further research is required to ensure that ERK and p38 MAPK activities 
are crucial for macrophage senescence since no differences in MAPKs 




example, it would be significant perform senescent biomarkers assays inhibiting 
specifically both kinases in long-term cultures of BMDM or using ERK and p38 MAPK 
knockout macrophages. 
Additionally, GM-CSF-dependent proliferation also induces the activation of STAT5 
signaling pathway which is involved in the growth of different cells such as 
macrophages. Long-period cultures of BMDM show a decrease in STAT5 
phosphorylation in response to GM-CSF stimulation. Corroborating these results, 
previous studies from our research group detected a reduction in STAT5 activity in 
BMDM obtained from old mice (Sebastián et al., 2009). 
Taken together, these effects on mRNA transcription of cell cycle regulators genes, the 
elongation of ERK1/2 and p38 MAPK activities and the reduction in STAT5 
phosphorylation may prevent transition from G1 to S phase, blocking the cell cycle and 
contributing to the induction of macrophage senescence program (Figure 37). 
However, cell cycle arrest is not a synonym of senescence. Non-senescent cell cycle 
blockage can be caused by the absence of growth factors which drives to cellular 
quiescence (Blagosklonny et al., 2011) or by terminal differentiation (Buttitta and 
Edgar, 2007). Thus, since senescence, quiescence and terminal differentiation are all 
described by the accumulation of cells at G1 phase of the cell cycle through high 
CDKIs activity (Lowe and Sherr, 2003; Pajalunga et al., 2007), it is difficult to 
distinguish these three processes in a cellular culture. Nevertheless, while quiescence 
is characterized by reversible cell cycle arrest, terminal differentiation is usually 
coupled with permanent exit from the cell cycle and represents the most common 
cellular state in adult animals (Liu et al., 2004). In this sense, quiescence seems not to 
be involved in the growth arrest presented in long-period cultures of BMDM since 
proliferative assays were performed with M-CSF and GM-CSF treatments. In addition, 
both processes, quiescence and terminal differentiation, can be ruled out due to the 
numerous senescent biomarkers shown in long-term cultures of BMDM which are 






Figure 37. Molecular mechanism involved in cell cycle arrest observed in long-period 
BMDM cultures.  Schematic model for the cell cycle blockage presented in long-period cultures 
of BMDM comparing the expression or activation of the main components and regulators with 
normal BMDM. Blue and pink arrows indicate the up- or downregulation of the corresponding 
genes and the increase or reduction in MAPKs and STAT5 phosphorylation in M-CSF- or GM-
CSF-dependent macrophage division, respectively, whereas black flattened arrows represent 
inhibitions of CDK/cyclin complexes. Equal signs indicate no differences between long-period 
and normal BMDM. Red spheres indicate phosphorylation, and blue and pink spheres represent 
M-CSF and GM-CSF growth factors, respectively. 
 
As it has been mentioned before, long-period cultures of BMDM express high levels of 
p16. Most senescent cells increase the expression of p16, which is not commonly 
expressed by quiescent or terminally differentiated cells (Alcorta et al., 1996; Hara et 
al., 1996; Serrano et al., 1997; Brenner et al., 1998; Stein et al., 1999). It is long known 
that p16 levels accumulate and cause growth arrest when cells approach their 
replicative life span (Itahana et al., 2003). Moreover, increased p16 expression is also 























al., 1998).  The capacity of different oncogenes to trigger senescence seems to depend 
on cell and tissue type, perhaps reflecting the integrity of tumor suppressor networks. 
Therefore, we also investigated the profile expression of the most important 
senescence-related oncogenes in long-term cultures of BMDM. In this regard, these 
senescent macrophages overexpress c-Myc and Raf oncogenes as well as E2F1.  
Although, some reports have described that development of senescence in different 
cell types is c-Myc-independent (He et al., 2008) or even could be associated with 
reduction in c-Myc expression (Guney et al., 2006; Mallette et al., 2007; Guo et al., 
2007), in general, overexpression of c-Myc has been related to apoptosis and 
senescence as a defense mechanism to control cell growth (Evan and Vousden, 2001; 
Campaner et al., 2010). Similarly and supporting our current observations, Raf and 
E2F1 upregulation is presented by senescent cells in a p53-independent mechanisms 
(Olsen et al., 2002; Chistoffersen et al., 2010).  
Numerous reports show convincingly that p53 and its downstream effector p21 or p16-
pRB signaling pathway play a key role in the regulation of cellular senescence 
mechanism (Lowe et al., 2004).  
Overexpression of p53 (Wang et al., 1998) and p21 (Brown et al., 1997; Stott et al., 
1998; Fang et al., 1999; Wang et al., 1999) autonomously induced senescence in 
human cells and activation of p53 (Wei et al., 2001) induced senescence in a p21-
dependent pathway in human diploid fibroblasts (HDF) and human glioblastoma cells, 
respectively. Moreover, inactivation of p53 prevents senescence in mouse embryonic 
fibroblasts (MEF) (Harvey and Levine, 1991) and human fibroblast lacking p21can 
bypass the senescence-related cell cycle exit (Hara et al.,1991). However, although 
long-period BMDM are able to induce p53 activity upon DNA damaging treatments and 
express p21 at similar levels as normal BMDM, at basal and growing conditions neither 
present p53 phosphorylation nor increase p21 mRNA expression, discarding this 
mechanism as the inductor of senescence in our macrophage senescent model.  
In addition, senescence can also be mediated by p16-pRB-dependent mechanism 
indicating the redundant role of p16 since it is implicated in the irreversible growth 
arrest and drives to the hyperphosphorylation and accumulation of pRB which initiates 
the senescence program. It has been demonstrated that p16-dependent activation of 
pRB causes formation of senescence-associated heterochromatin foci (SAHF), which 
silence critical pro-proliferative genes (Narita et al., 2003). Moreover, the importance of 
p16 in the induction of senescence is clear as p16-/- cells can be driven into 




extraordinary high expression of p16 in long-term cultures of BMDM makes us suspect 
that p16-pRB pathway is the mechanism involved in the induction of senescence in 
these macrophages. Nevertheless, further studies will be required to elucidate the 
molecular events that regulate the senescence program in long-period cultures of 
BMDM and whether this mechanism is correlated with the presenting macrophages 
obtained from old mice. 
Consistent with evidences provided in this thesis, p16 overexpression is related to 
telomeric or intrachromosomal DNA damage (Brenner et al., 1998; Robles and Adami, 
1998; Ramirez et al., 2001; te Poele et al., 2002; Jacobs and de Lange, 2004; Le et al., 
2010). Consequently, we decided to study the involvement of telomere attrition in the 
induction of senescence-associated impaired proliferative capacity in long-period 
BMDM. We show that the activation of telomerase through TA-65 pre-treatment 
moderately improves normal macrophage proliferation in senescent macrophages. TA-
65 is a drug that is able to activate telomerase and enhance growth in vitro as well as 
in vivo senescence-related or aged-related models (Hartwig et al., 2012; Boccardi and 
Paolisso, 2014). Our results also accord with several studies done on both rodents and 
humans using telomerase activators (Molgora et al., 2013, Taka et al., 2014). 
Bernardes de Jesús and co-workers demonstrated that mice treated with TA-65 
elongated short telomeres affecting telomerase activity and increasing life span without 
incidence of cancer (Bernardes de Jesús et al., 2011). Other report describing initial 
research in aged humans treated with TA-65 provided evidences of the improvement of 
certain immune parameters that had previously been associated with beneficial health 
effects (Harley et al., 2011). In this sense, our findings revealed that telomeres 
shortening presented in long-term cultures of BMDM contributes significantly to the 
irreversible cell cycle arrest induced in these macrophages.  
However, a better understanding of these processes may facilitate new approaches 
which elucidate the complete mechanism of senescence induction in long-term cultures 
of BMDM connecting all participators: cell cycle exit, telomeres attrition, enhanced 
oxidative stress and DNA damage. 
 
M-CSF- and GM-CSF-dependent DNA repair is not affected in long-period 
cultures of BMDM  
To protect the integrity of their DNA, cells need to be able to sense DNA damage and 




H2AX phosphorylation is induced by DSBs and is able to activate the repair machinery. 
The molecular mechanism involves ATM and ATR kinases which are important DNA 
damage checkpoints that activate other kinases such as Chk1 (activated by ATR) and 
Chk2 (activated by ATM). These kinases also phosphorylate and activate the tumor 
suppressor protein p53. ATM and ATR can additionally enhance p53 activity by 
directing p53 phosphorylation on Ser15. Activated p53 can halt progression of the cell 
cycle in the G1 phase, allowing DNA repair, apoptosis or senescence induction, 
depending on the cellular situation, to prevent the transmission of damaged DNA to the 
daughter cells (Di Micco et al., 2006; Bartkova et al., 2006). 
However, although we are able to detect high levels of Ɣ-H2AX after M-CSF and GM-
CSF treatments in senescent macrophages, they do not show p53 activation in the 
same conditions. These results suggest that DDR induced in long-term cultures of 
BMDM at growing conditions is p53-independent. In contrast, senescent macrophages 
are able to phosphorylate p53 upon H2O2 stimulation, indicating that p53 activation is 
not impaired. In this regard, while p53 is required for normal induction of cell death 
following DNA damage, (Yuan et al., 1999; Irwin et al. 2003; Urist et al. 2004; Ozaki 
and Nakagawara, 2005; Roos and Kaina, 2006), several reports confirm the activation 
of H2AX independently of p53 phosphorylation (Reinhardt et al., 2007; Sidi et al., 2008; 
Valentine et al., 2011). 
This p53-independent alternative DDR mechanism has been associated with a reduced 
or delayed apoptosis (McNamee and Brodsky, 2009). Although senescence is 
considered as tumor-suppressive mechanism that promotes apoptosis of cells, the 
induction of senescence in certain cell types, such as fibroblasts (Kim et al., 2011) and 
T-cells (Monti et al., 2000), may result in resistance to apoptosis whose accumulation 
contribute to the pathogenesis of certain age-related diseases (Raghu et al., 2006; 
Beltrami et al., 2012). Consistently, apoptosis induced in senescent macrophages is 
decreased. This resistance to apoptosis has been related with the up-regulation of 
several anti-apoptotic genes such as Bcl-2 (Wang, 1995; Ryu et al., 2007) and survivin 
(Al-Khalaf and Aboussekhra, 2012). According to published data, long-period cultures 
of BMDM also present high levels of Bcl-2 mRNA expression which contributes to 
reduce apoptosis.  
Although M-CSF and GM-CSF induce different mechanisms for proliferation, they 
share the same signaling cascade for survival in macrophages which consists in the 
activation of PI-3K-Akt pathway (Comalada et al., 2004). In this sense, the protective 




macrophages and dendritic cells (Galeazzi et al., 2000; Xu et al., 2008; Bernasconi et 
al., 2010; Egea et al., 2013; Li et al., 2013) and in alveolar macrophages (Bernier et al., 
2001; Cakarova et al., 2009). Additionally, the repair machinery induced by DDR 
produced by oxidative stress is not affected by the senescent program due to the ability 
of senescent macrophages to reduced H2AX phosphorylation after M-CSF and GM-
CSF recovery conditions. These results suggest that the accumulation of DNA damage 
in long-period cultures of BMDM is not produced by an impaired repair capacity. 
 
 
Macrophage functions are altered in long-period cultures of BMDM 
As the average human life expectancy has increased, the impact of aging and age-
related disease has become the focus of many research groups. The appearance of 
chronic inflammatory pathologies is common in the elderly and it has been linked with 
an abnormal development of the inflammatory response (Franceschi et al., 2000; 
Tracy, 2003; Kerr, 2004; Casseta and Gorevic, 2004; Krabbe et al., 2004; Casserly and 
Topol, 2004; Hakim et al., 2004). Thus, deficiencies in innate and adaptive immunity 
diminish the efficiency to eliminate pathogens and restore homeostasis in the context 
of infectious disease and wound healing.  Investigation in immune aging centers on the 
development of treatments which increase the quality of life in the elderly population 
through immune response modulation.  In order to modify immune function, it is 
essential to understand the mechanisms underlying age-related functional 
impairments.  
As macrophages represent a first line of defense against invading pathogens and a link 
between innate and adaptive immunity, altered macrophages functions are critical for 
immunosenescence and inflammaging development. However, the impact of advanced 
aged on these processes seems to be controversial. For instance, some published 
reports showed no significant effect on monocytes recruitment while other observed an 
important delay and reduced number of monocytes (Ashcroft et al., 1998; Swift et al., 
1999; Swift et al., 2001; Plackett et al., 2004).  
Our work provides further evidences for the impaired classical and alternative 
activation of senescent macrophages which can contribute to dysregulate the immune 




Regarding to altered M1 functions, we show a declined antigen presentation 
represented with low levels of class II MHC expression on the surface of senescent 
macrophages in response to IFN-γ. This data is consistent with previous results from 
our research group which observed decreased expression of MHC II in macrophages 
from old mice (Herrero et al., 2002). This reduced antigen presentation has been also 
reported in aged humans (Effros and Walford, 1984; Seth et al., 1990; Haruna et al., 
1995; Garg et al., 1996; Zissel et al., 1999).  Moreover, this defective antigen 
presenting capacities is connected with impaired adaptive immunity since provokes 
less T cell activation and clonal expansion (Plowden et al., 2004). 
Additionally, long-period cultures of BMDM also exhibit reduced microbicidal activity. 
NOS2, the enzyme that synthetizes NO, mRNA and protein expression is attenuated in 
this cells. In this regard, it is not surprising that NO production is declined in senescent 
macrophages comparing with normal BMDM in response to LPS or LPS plus IFN-γ. 
Since NO is a powerful and crucial toxic molecule which mediates bacterial wall lysis 
and, therefore, pathogen killing, impaired synthesis of NO may produce deficiencies in 
pathogen clearance which can lead to increased bacterial burden (Frazier et al., 2009).  
Our findings are in concordance with in vitro and in vivo reported results (Tschudii et 
al., 1996; Cernadas et al., 1998; Matsushita et al., 2001) indicating that macrophage 
intracellular anti-bacterial activity is impaired in senescent macrophages.  
Senescence effects on M1 macrophage activity are not limited to antigen presentation 
and pathogen elimination, cytokine expression is also affected. The mRNA and protein 
expression as well as the secretion of pro-inflammatory cytokines such as IL-1β and 
TNF-α are increased in response to LPS in long-term cultures of BMDM.  
In the case of IL-1β, LPS stimulation is not sufficient to induce the release of IL-1β, but 
the activation of inflammasome is required (Lamkanfi and Dixit, 2012). Inflammasomes 
are intracellular multiprotein complexes that assemble in response to a diverse range 
of microbial products and also to endogenous danger signal after specific recognition 
through NLRs, expressed in innate immune cells (von Moltke et al., 2013). 
Consequently, we determined IL-1β production activating the most studied 
inflammasome mechanism: the NLRP3 inflammasome activation through ATP 
signaling (Halle et al., 2008; Elinav et al., 2013). Although IL-1β is overexpressed and 
secreted by senescent endothelial cells (Maier et al., 1990), fibroblasts (Kumar et al., 
1992; Rinehart et al., 1999), and chemotherapy-induced senescent epithelial cells 
(Chang et al., 2002), we cannot ruled out the effects of senescence induction on 




demonstrated the involvement of MAPKs, transcription factors, ROS production and 
phagocytosis in inflammasome expression and activation which can also affect IL-1β 
levels (Cogswell et al., 1994; Baldassare et al., 1999; Stutz et al., 2009; Sheibel et al., 
2010; Cai et al., 2012; Fields and Ghorpade, 2012; Qu et al., 2012; Qiao et al., 2013). 
Similarly, TNF-α production is increased in senescent macrophages. This is consistent 
with published data where showed high levels of circulating TNF-α in aged individuals 
(Bruunsgaard, 2006) as well as increased TNF-α production produced by NK cells 
(King et al., 2009) and B cells (Ratliff et al., 2013) from aged mice. Moreover, we also 
evaluated the expression and release of IL-10, a well-known anti-inflammatory cytokine 
which controls TNF-α and other pro-inflammatory cytokines effects at systemic level. 
The induction of senescence on macrophages also increases the expression and 
secretion of IL-10 which can be explained by the enhanced STAT-3 phosphorylation 
exhibit in long-period cultures of BMDM in response to LPS.  This finding is also in 
concordance with the involvement of STAT-3 activation for premature cytokine-induced 
senescence development observed in human fibroblasts (Kojima et al., 2013). 
This altered cytokine secretion induced in senescent macrophages can be described 
by the potential SASP development. SASP phenotype consists in differences in the 
production of several factors that can affect neighboring cells by activating receptors 
and inducing signal transduction pathways. These factors can be divided in soluble 
signaling mediators, including cytokines (IL-6, IL-1β, TNF-α), chemokines (MCP-2, 
CXCL-1, -2, -8) and growth factors (GM-CSF), and in secreted proteases (PAI-1, -2)  
and ECM components (MMP-1, -3, -10) (Coppé et al., 2014).  
In this sense, the results obtained suggest that our macrophage senescent model 
presents an altered pro- and anti-inflammatory cytokine profile which can participate 
significantly to the defective immune response against pathogen infection observed in 
aged organisms. 
Next, we explored the potential role of TLRs in altered M1 functions observed in long-
term cultures of BMDM. Activation of TLRs in macrophages usually drives to the 
transcriptional regulation of pro-inflammatory and antiviral cytokines and chemokines 
that modulate the innate immune response. Therefore, impaired TLRs signaling can be 
determinant for the acquisition of SASP phenotype which leads to inflammation 
imbalance (Olivieri et al., 2013). In this regard, the expression of TLRs and the 
signaling pathway involved has been investigated in immune cells of aged/senescent 
murine and human models resulting in important changes in TLRs expression that 




To address this question, we measured the surface protein expression of TLR-2, -4 
and -5 and the intracellular protein expression of TLR-9 in normal and senescent 
macrophages at basal and activated conditions. We selected these four TLRs due to 
the reported evidences of different expression levels in aged murine and human 
models whereas rest of TLRs seem not to be affected by aging (Sun et al., 2010; Sun 
et al., 2012). Our work indicates that long-term cultures of BMDM up-regulate TLR-4, -5 
and -9 whereas TLR-2 protein expression is down-regulated in response to LPS, 
indicating a putative link between altered TLRs expression and inflammaging in our 
macrophage senescent model. However, in absence of stimulation normal and 
senescent macrophages express similar TLRs levels, as it has been previously 
published in neutrophils and macrophages (Bohemer et al., 2004; Sun et al., 2012).  
TLR-2 together with TLR-1 or TLR-6 detects various bacterial components including 
peptidoglycan, lipopeptide and lipoprotein of gram-positive bacteria. The down-
regulation of TLR-2 observed in senescent macrophages may be responsible to the 
aged-related decline of the immune response to gram positive bacteria observed in 
vivo (Boyd et al., 2012). However, it has been also published a slightly increased in 
TLR-2 expression in alveolar macrophages, suggesting also defects in signal 
transduction (Boyd et al., 2012). TLR-4 and TLR-5 recognize LPS and bacterial 
flagellin, respectively, inducing a signaling cascade which results in increasing the 
secretion of pro-inflammatory cytokines such as TNF-α and IL-1β. Both receptors are 
overexpressed in long-term cultures of BMDM that can amplify the signaling 
transduction and explain the increase in TNF-α and IL-1β production observed in 
senescent macrophages. Additionally, TLR-4 and TLR-5 expression was reported to be 
higher in old rhesus macaques compared to younger animals although in humans are 
unaltered (Fulop et al., 2004; Murciano et al., 2007; Asquith et al., 2012). In the case of 
TLR9, which detects viral and bacterial DNA and although published results showed 
unclear results, it has been reported that TLR-9 knockout lymphocytes induces earlier 
senescence in these mice produced by pro-inflammatory properties (Abu-Tair et al., 
2013). In contrast, our results indicate an overexpression of TLR-9 in senescent 
macrophages. However, we do not have data about levels of IFN type I expression or 
secretion. In this sense, further investigations are required to connect TLRs expression 
and signal transduction with altered pro-inflammatory profile observed in senescent 
macrophages.  
Regarding to M2 altered functions, our data indicate clearly a suppressed alternative 
activation in long-period cultures of BMDM in response to IL-4. Using established 




significantly reduced as well as fizz1 expression, a crucial transcription factor for M2 
differentiation, and mgl1, a receptor for C-type lectins that recognizes galactose 
residues expressed in pathogens (Roszer, 2015). In contrast, tgfb and mrc1 mRNA 
levels are not affected or even increase, respectively, in senescent macrophages. This 
may be explained due to tgfb and mrc1 expression is mediated by STAT-3 signaling 
pathway (Sica and Mantovani, 2012) which is overactivated in long-term cultures of 
BMDM, as we mentioned before. Moreover, although tgfb and mrc1 are considered M2 
markers, since they are overexpressed during parasite infection and in allergic asthma 
(Roszer, 2015), their expression is not restricted to M2 macrophages (Barros et al., 
2013) 
At endothelial level there are evidences that relate high arginase activity with aging. It 
has been reported that high arginase activity, low NO production and increased ROS 
levels are presented in old rats which result in promoted fibrosis (Kim et al., 2009). In 
fact, knocking down arginase-1 (White et al., 2006) restores aging-related endothelial 
senescence and improves vascular function (Bivalacqua et al., 2007). Nevertheless, 
consistently with our data Mahbub and co-workers demonstrated that IL-4-dependent 
arginase-1 and fizz1 mRNA expression was reduced in splenic macrophages and in 
BMDM from aged mice (Mahbub et al., 2012). Additionally, for the first time, herein we 
show altered mgl1 mRNA expression associated with cellular senescence in 
macrophages.  
Therefore, taking into account the critical role of arginase1, fizz1 and mgl1 in control 
the resolution of inflammation and in parasitic infection, the results obtained indicate 
the inability of senescent macrophages to repair tissues and to orchestrate an 
appropriate M2 response during parasite invasion resulting in inflammatory imbalance 
and in susceptibility to Th2-pathologies (Hesse et al., 2001; Loke et al., 2007; Nair et 
al., 2009; Pesce et al., 2009). 
Furthermore, we also investigated the phagocytic ability of senescent macrophages to 
eliminate apoptotic cells. The evidence for impaired phagocytic capacity of long-term 
cultures of BMDM was evaluated through fluorescence microscopy and by flow 
cytometry experiments using apoptotic GFP-epithelial cells. Whereas 80% of normal 
macrophages are positive for green fluorescence after apoptotic fibroblast challenge, 
only 40% of senescent macrophages are able to engulf apoptotic fibroblasts. On the 
other hand, although we have some preliminary results showing that pathogen 
clearance by macrophage phagocytosis is also suppressed in long-term cultures of 




common or whether are produced by signal transduction deficiencies. In contrast to 
pathogen elimination, apoptotic cells are immunosuppressive. Apoptotic cells clearance 
by phagocytes induce the inhibition of the pro- inflammatory cytokines TNF-α, GM-
CSF, IL-12, IL-1β and IL-18 through the promotion of anti-inflammatory cytokines IL-10 
and TGF-β (Birge and Ucker, 2008). Moreover, phagocytes present antigens from 
apoptotic cells to T cells maintaining the peripheral immune tolerance (Steinman and 
Nussenzweig, 2002; Steinman et al., 2003). In this sense, defective or delayed 
phagocytosis of apoptotic cells may result in the development of autoimmune diseases 
such as systemic lupus erythematosus (SLE) or cystic fibrosis (Liu and Mohan, 2006). 
However, research works regarding the influence of aging on macrophage phagocytic 
function are controversial. De La Fuente and co-workers demonstrated a decrease in 
macrophage phagocytosis in old mice compared with young mice (De La Fuente, 
1985). Aprahamian and collaborators demonstrated an age-related reduction in 
phagocytosis of apoptotic cell debris in mice in vivo but not in vitro (Aprahamian et al., 
2008). Furthermore, human studies have reported impaired phagocytosis by 
macrophages from older individuals (Hearps et al., 2012), while earlier studies reported 
no effect of aging on phagocytic function in humans (Fietta et al., 1994). 
Therefore, this work provides relevant evidences of damaged M1 and M2 activities 
(summarized in Figure 38) in our novel senescent macrophage model that correlate 
with that observed in macrophages from aged mice as it was previously demonstrated 







Figure 38. Impaired functional activities in long-term cultures of BMDM.  Schematic 
representation of altered classical and alternative macrophage phenotypes of senescent 
macrophages. Proliferation in response to M-CSF and GM-CSF, antigen presentation, 
phagocytosis of apoptotic cells, microbicidal activity as well as tissue repair capacities are 
reduced in long-term cultures of BMDM comparing with normal macrophages. On the contrary, 
pro-inflammatory cytokines, such as TNF-α and IL-1β, and ROS production are increased in 
these macrophages. Red arrows indicate the reduction or increase in macrophage capabilities 
comparing with normal BMDM. 
 
 
Long-term cultures of BMDM should be considered as a good cellular 
model for macrophage age-related studies  
Although there are two main theories which try to explain age-related impairments in 
macrophages, the intrinsic defects hypothesis (Yoon et al., 2004) and the 
microenvironment effects hypothesis (Chen et al., 1996; Mahbub et al., 2012), based 
on our data, this thesis clearly demonstrate senescence-associated macrophage 
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believe that due to the high plasticity of macrophages and their rapid adaptation to 
environmental changes, the microenvironment also plays a key role in macrophage 
function participating and contributing to the intrinsic macrophage dysfunction.  
The effect of aging on macrophages appears to be multifaceted, affecting almost every 
aspect of their normal cellular function (Murciano et al., 2007; Pott et al., 2012; Olivieri 
et al., 2012; Qian et al., 2012). We have demonstrated that long-term cultures of 
BMDM present a wide range of senescent characteristics that allow identify these cells 
as senescent macrophages. Additionally, the impaired proliferative capacity featured by 
cell cycle arrest at G1 phase, the suppressed M1 and M2 functionality and the 
damaged phagocytosis of apoptotic cells observed in our novel senescent macrophage 
model is in concordance with bibliographic data. 
To our knowledge, this is the first time that has been achieved a senescent cellular 
model of macrophages that resembles macrophage deficiencies from aged mice. 
Therefore, we demonstrate that long-term cultures of BMDM are a relevant cellular 
model to study different aging-related processes on macrophages including 
proliferation, senescence mechanisms, classical and alternative macrophage 



































Long-term cultures of BMDM are senescent macrophages and the molecular 
mechanism involved in cell cycle arrest has been provided 
 
1. Long-term cultures of BMDM are positive for SA-β gal activity and present 
reduced proliferative capacity in response to M-CSF and GM-CSF, altered 
morphology, telomeres shortening, high DNA damage, increased ROS 
production and apoptosis resistance. 
 
2. Cell cycle blockage at G1 phase observed in long-term cultures of BMDM is 
induced by an overexpression of p16 and p27 as well as by suppressed 
expression of cyclinD1, cyclinE, Cdk2 and Cdk4. In addition, upregulation of c-
Myc, Raf and E2F1 also contribute to the impaired cell cycle progression. The 
signaling pathway involved in cell cycle arrest observed implicate sustained 
ERK and p38 MAPK activation and reduced STAT5 phosphorylation. 
 
3. Accumulation of DNA damage shown in long-term cultures of BMDM is not 
produced by impaired DNA repair machinery. 
 
4. p16 pathway and telomere shortening are involved in the induction mechanism 




Classical and alternative macrophage functions are compromised in long-term 
cultures of BMDM 
 
1. Long-term cultures of BMDM exhibit suppressed antigen presentation capacity 
and microbicidal activity. 
 
2. TLR-2, -4, -5 and -9 profile expression is altered in long-term cultures of BMDM 
which is associated with the increased secretion of IL-1β, TNF-α and IL-10. 
 
3. Arginase-1, fizz1 and mgl1 mRNA expression is reduced in M2 senescent 
macrophages whereas other M2 markers (tgfb and mrc1) are not affected. 
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